Application_Number cess Pate Secondary Title Classific Abstract Inventor 00275/KOLNP/2005 1 0 #N/A #N/A #N/A #N/A 00523/DELNP/2004 1 0 A method A61K-31/0 A topical 0081/DEL/2001 1 0 A process A61K-31/0 The prese 0088/DEL/2001 1 0 a process A61-K 31/ A process 0090/DEL/2001 1 0 A process A61-K 31/ The prese 00951/DELNP/2003 1 0 "A METHOD A61K-9/10 The prese 01005/DELNP/2003 1 0 "A Proces A61K-38/4 A process 01042/KOLNP/2004 1 0 "PROCESS A61K-31/5 A process 01448/DELNP/2003 1 0 PROCESS F A61K-31/0 The prese 01479/KOLNP/2003 1 0 METHOD OF A61K-9/28 An ingest 01584/KOLNP/2004 1 0 A PROCESS A61K-31/4 The enol 01622/KOL-NP/2003 1 0 #N/A #N/A #N/A #N/A 01622/KOLNP/2003 1 0 #N/A #N/A #N/A #N/A 0173/DEL/2001 1 0 "PROCESS A61K-31/5 The inven 01863/KOLNP/2004 1 0 A METHOD A61-K 35/ The inven 02135/DELNP/2003 1 0 "PROCESS A61K-31/4 Process f 0846/DELNP/2003 1 0 PROCESS F A61-K 7/4 Phenylene 0851/DEL/1999 1 0 "PROCESS A61K-31/0 1. Proces 1011/MUM/2008 1 0 COMPOUNDS A61K-1/00 Steroidal 1014/CHE/2005 1 0 AN IMPROV A61K-31/3 The prese 1015/KOL/2006 1 0 METHODS F A61K-31/4 This inve 1018/MUM/2000 1 0 A PROCESS A61-K 9/2 1. A meth 1022/DEL/1996 1 0 "AN IMPRO A61K-31/1 An improv 1023/DEL/2002 1 0 "A METHOD A61K-9/00 The prese 1024/DEL/2006 1 0 "A PROCES A61K-35/7 The prese 1025/MUMNP/2005 1 0 A PARTICU A61K-47/36 1025/MUM/2003 1 0 A PROCESS A61K-9/00 The inven 1031/DEL/2000 1 0 AN IMPROV A61K-31/0 A process 1031/MUM/2003 1 0 IMPROVED A61K-31/0 ABSTRACT TYAGI, OM 1034/CHE/2009 1 0 IMPROVED A61K-31/4 ABSTRACT 103/DELNP/2005 1 0 "A METHOD A61K-9/28 A method 103/DEL/2002 1 0 "PROCESS A61K-35/6 A process 1040/DEL/2003 1 0 "PROCESS A61K-31/0 The prese 10441/DELNP/2008 1 0 "COMPOSIT A61K-9/00 A process 1044/MUMNP/2007 1 0 PROCESS F A61K-47/4 A process 1045/DEL/1998 1 0 "A METHOD A61K-31/4 The prese 1048/CHENP/2003 1 0 A NOVEL P A61K-31/5 Cilazapri 104/CHE/2007 1 0 NOVEL PRO A61K-31/0 Abstract 1050/DEL/2001 1 0 "AN IMPRO A61K-031/ The prese 1051/DEL/1998 1 0 " PROCESS A61K-31/0 The prese 1051/KOLNP/2008 1 0 A METHOD A01N- 63/ (57) Th 1053/DEL/1996 1 0 "A PROCES A61K-31/0 A process 1054/DELNP/2004 1 0 "METHOD F A61K-9/16 A method JEPSEN SV 1054/DEL/2003 1 0 A process A61-K 31/ The inven David Pau Thottappi Thottappi Thottappi RAJARAM S Pilar Pic COOTE STE PREMCHEND NOWAK EDW BARTOLINI PERDRIEUX EVANS CHR PETER SIE ROLAND LA HERBERT M AMIRANASH MEENAKSHI Azaam All CHANDAVAR LALGUDI V RAJIV MAL AMIT NAYY ERACLIS S PATEL, PA SANJAY NA KARAKAL S ALFONS GR SINGH JAS DINOS PAU KIECKBUSC GREENWALD HUBERTUS MURALIDHA DR. CHAVA YATENDRA HERMAN PI MOGNA GIO RAJENDRA Praveen K
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Application_NumberProcess PatentsSecondary Title Classificat Abstract Inventor Applicant00275/KOLNP/2005 1 0 #N/A #N/A #N/A #N/A #N/A00523/DELNP/2004 1 0 A method oA61K-31/0A topical o Healthpoint, Ltd.,::US::US0081/DEL/2001 1 0 A process fA61K-31/0The present Council of Scientific and Industrial Research::IN::IN0088/DEL/2001 1 0 a process fA61-K 31/0A process f Council of Scientific and Industrial Research::IN::IN0090/DEL/2001 1 0 A process fA61-K 31/1The present Council of Scientific and Industrial Research::IN::IN00951/DELNP/2003 1 0 "A METHODA61K-9/10The present BAXTER INTERNATIONAL INC.::US::US01005/DELNP/2003 1 0 "A ProcessA61K-38/4A process f Healthpoint, Ltd.::US::US01042/KOLNP/2004 1 0 "PROCESS A61K-31/5A process f GLAXO GROUP LIMITED::GB::GB01448/DELNP/2003 1 0 PROCESS FA61K-31/0The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN01479/KOLNP/2003 1 0 METHOD OFA61K-9/28An ingestib BIOPROGRESS TECHNOLOGY INTERNATIONAL INC::US::US01584/KOLNP/2004 1 0 A PROCESSA61K-31/4The enol ta POLIFARMA S.P.A.::IT::IT01622/KOL-NP/2003 1 0 #N/A #N/A #N/A #N/A #N/A01622/KOLNP/2003 1 0 #N/A #N/A #N/A #N/A #N/A0173/DEL/2001 1 0 "PROCESS A61K-31/5The inventi ATOFINA::FR::FR01863/KOLNP/2004 1 0 A METHOD A61-K 35/0The inventi THE BRIGHAM AND WOMEN'S HOSPITAL INC.::US::US02135/DELNP/2003 1 0 "PROCESS A61K-31/4Process for BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG.::DE::DE0846/DELNP/2003 1 0 PROCESS FA61-K 7/42Phenylene-b SYMRISE GMBH & CO. KG.::DE::DE0851/DEL/1999 1 0 "PROCESS A61K-31/01. Process LANXESS DEUTSCHLAND GMBH,::DE::DE1011/MUM/2008 1 0 COMPOUNDSA61K-1/00Steroidal d SHELAR ASHOK RANGANATH::IN::IN1014/CHE/2005 1 0 AN IMPROVA61K-31/3The present AUROBINDO PHARMA LIMITED::IN::IN1015/KOL/2006 1 0 METHODS FA61K-31/43This invent JOHNSON & JOHNSON VISION CARE, INC.,::US::US1018/MUM/2000 1 0 A PROCESSA61-K 9/201. A method FDC LIMITED::IN::IN1022/DEL/1996 1 0 "AN IMPROA61K-31/1An improved COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1023/DEL/2002 1 0 "A METHODA61K-9/00The present RANBAXY LABORATORIES LIMITED::IN::IN1024/DEL/2006 1 0 "A PROCESA61K-35/7The present NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH::IN::IN1025/MUMNP/2005 1 0 A PARTICUA61K-47/36 ADISSEO FRANCE SAS::FR::FR1025/MUM/2003 1 0 A PROCESSA61K-9/00The inventi CADILA HEALTHCARE LTD::IN::IN1031/DEL/2000 1 0 AN IMPROVA61K-31/0A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1031/MUM/2003 1 0 IMPROVED A61K-31/0ABSTRACT ImTYAGI, OM LUPIN LTD.::IN::IN1034/CHE/2009 1 0 IMPROVED A61K-31/4ABSTRACT Th GLAND PHARMA LTD::IN::IN103/DELNP/2005 1 0 "A METHODA61K-9/28A method of BAYER HEALTHCARE AG,::DE::DE103/DEL/2002 1 0 "PROCESS A61K-35/6A process f PANACEA BIOTECH LIMITED::IN::IN1040/DEL/2003 1 0 "PROCESS A61K-31/0The present10441/DELNP/2008 1 0 "COMPOSITA61K-9/00A process f NOVARTIS AG::CH::CH1044/MUMNP/2007 1 0 PROCESS FA61K-47/4A process f ENZON PHARMACEUTICALS, INC.::US::US1045/DEL/1998 1 0 "A METHODA61K-31/4The present DSM N.V..,::NL::NL1048/CHENP/2003 1 0 A NOVEL PA61K-31/5Cilazapril M/S. HETERO DRUGS LIMITED::IN::IN104/CHE/2007 1 0 NOVEL PROA61K-31/0Abstract Th MYLAN LABORATORIES LTD::IN::IN1050/DEL/2001 1 0 "AN IMPROA61K-031/The present RANBAXY LABORATORIES LIMITED::IN::IN1051/DEL/1998 1 0 " PROCESSA61K-31/0The present DSM N.V.::NL::NL1051/KOLNP/2008 1 0 A METHOD A01N- 63/0(57) The Anidral S.R.L.::IT::IT1053/DEL/1996 1 0 "A PROCESA61K-31/0A process f THE CHIEF CONTROLLER RESEARCH & DEVELOPMENT::IN::IN1054/DELNP/2004 1 0 "METHOD FA61K-9/16A method foJEPSEN SVEFERRING BV::NL::NL1054/DEL/2003 1 0 A process fA61-K 31/0The inventi Council of Scientific and Industrial Research::IN::IN1056/CHE/2004 1 0 "AN IMPROA61K-31/0The present ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN1058/DEL/2001 1 0 ''A PROCESA61K-9/19The long ch#N/A1060/MUM/2003 1 0 A PROCESSA61K-31/4the inventi
David Wayne Hobson::US::USDavid Paul Jones::US::USSunil Ramchandra Bhide::IN::INThottappillil Ravindranathan::IN::INSunil Ramchandra Bhide::IN::INThottappillil Ravindranathan::IN::INSunil Ramchandra Bhide::IN::INThottappillil Ravindranathan::IN::INJANE WERLING::US::USRAJARAM SRIRAM::US::USKatarzyna Koster::US::USPilar Picon Duque::US::USNICE ROSALYN KAY::GB::GBCOOTE STEVE N JOHN::GB::GBVEERA KOGARA MADHUSUDAN REDDY::IN::INPREMCHENDAR NANDIKONDA::IN::INPOVEY IAN DAVID::GB::GBNOWAK EDWARD ZBYGNIEW::GB::GBCORNIELLO CRISTINA::IT::ITBARTOLINI BARBARA::IT::IT
1062/DEL/2002 1 0 "A NOVEL A61K-31/0A novel pro COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1067/DEL/2000 1 0 "A PROCESA61K-31/4New benzimi FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (FAES)::ES::ES1068/DEL/2000 1 0 "A PROCESA61K-31/4New benzixn FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (FAES)::ES::ES106/DEL/1997 1 0 "AN EFFECA61K-7/50The present COLGATE-PALMOLIVE COMPANY::US::US1070/DEL/2000 1 0 "A PROCESA61K-31/4A process FAES FARMA, S.A.::ES::ES1081/CHE/2003 1 0 AN IMPROVA61K-31/5Present inv NATCO PHARMA LTD::IN::IN1087/DEL/2002 1 0 A PROCESSA61K-31/0A process f COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN1088/DELNP/2007 1 0 "PROCESSEA61K-31/4A process f108/DEL/2004 1 0 "PROCESS A61K-31/0This invent JUBILANT ORGANOSYS LIMITED::IN::IN1090/DELNP/2003 1 0 A PROCESSA61K-31/1The present NACTILUS AB,::SE::SE1090/MAS/1998 1 0 A PROCESSA61K-9/00ABSTRACT 10 M/S. THE BOOTS COMPANY PLC::GB::GB1092/MUM/2004 1 0 PROCESS FA61K-9/20A processinPATRAVALE1)PATRAVALE VANDANA BHARAT 2)KHAN IMRAN AHMAD::IN::IN1092/MUM/2008 1 0 PROCESS FC07D-401/1Disclosed h1094/MUM/2003 1 0 A PROCESSA61K-31/0The present SUN PHARMACEUTICAL INDUSTRIES LTD.::IN::IN1097/DEL/2000 1 0 " A PROCESA61K-31/0The present RANBAXY LABORATORIES LIMITED::IN::IN1097/MUM/2003 1 0 A PROCESSA61K-31/7A PROCESS UNICHEM LUNICHEM LABORATORIES LIMITED::IN::IN10/MUMNP/2005 1 0 HAIR TRE A61-K 7/061. A metho HINDUSTAN LEVER LIMITED::IN::IN1100/DEL/1995 1 0 " A PROCE A61K-35/7A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1107/MUM/2003 1 0 A PROCESSA61K-047/1. A procesDEVARAJANDEVARAJAN PADMA VENKITACHALAM::IN::IN110/CHENP/2003 1 0 VACCINES A61K-39/0The present M/S. CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND::US::US1110/CHE/2005 1 0 AN IMPROVA61K-31/0The present ORCHID CHEMICALS AND PHARAMACEUTICALS LTD::IN::IN1115/DELNP/2005 1 0 "METHOD FA61K-51/0A method fo GE HEALTHCARE AS.::NO::NO1115/MAS/2000 1 0 A PROCESSA61K-9/50A process f SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES & TECHNOLOGY::IN::IN1115/MUM/2003 1 0 A PROCESSA61K-47/0A process fKARE, SUREM/S. INDOCO REMEDIES LIMITED::IN::IN1123/MUM/2002 1 0 A PROCESSA61K-031/This inventSHAH AMIT SHAH AMIT NAVNIT::IN::IN1123/MUM/2004 1 0 PROCESS FA61K-31/4Process for EMCURE PHARMACEUTICALS LIMITED::IN::IN112/DEL/2002 1 0 "A PROCESA61K-47/0The present RANBAXY LABORATORIES LIMITED::IN::IN112/KOLNP/2005 1 0 PROCESS FA61K-31/7A process fCARLINO, LABORATOIRE MEDIDOM S. A.::CH::CH1131/KOLNP/2007 1 0 A METHOD A61K-9/28The presentSCHAFFLERNITEC PHARMA AG.::CH::CH113/DEL/2001 1 0 "A PROCESA61K-31/0A process f COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN1141/MUM/2003 1 0 A METHOD A61-K 9/46A novel metDHARMENDRSKYMAX LABORATORIES PVT LTD.::IN::IN1142/MUM/2003 1 0 A NOVEL MA61K-9/00A novel metDHARMENDRSKYMAX LABORATORIES PVT LTD.::IN::IN1152/DEL/1999 1 0 AN IMPROVA61K-9/34The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1152/KOL/2007 1 0 PROCESS FC07D-209/8The present LUPIN LIMITED::IN::IN1156/DEL/2002 1 0 "A PROCESA61K-31/1The present RANBAXY LABORATORIES LIMITED::IN::IN1158/MUM/2003 1 0 PROCESS FA61K-031/A process f M/S. CIPLA LIMITED::IN::IN1165/DEL/2002 1 0 "A PROCESA61K-31/0The present NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER),::IN::IN116/DEL/2001 1 0 "A PROCESA61K-31/3A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN116/MUM/2009 1 0 A PROCESSA61K-31/18The present AARTI HEALTHCARE LIMITED::IN::IN1176/MUMNP/2007 1 0 A PHARMACA61K-31/3This invent ANACOR PHARMACEUTICALS, INC.::US::US1176/MUM/2004 1 0 THE PROCEA61K-31/0The process SONIC BIOCHEM EXTRACTIONS LTD.::IN::IN1177/MUM/2004 1 0 THE PROCEA61K-36/0An industri SONIC BIOCHEM EXTRACTIONS LTD::IN::IN1178/MUM/2004 1 0 ââ‚A61K-31/4A process o SONIC BIOCHEM EXTRACTIONS LTD::IN::IN117/MUMNP/2011 1 0 PROCESS FA61K-9/16,Process A p CRITICAL PHARMACEUTICALS LIMITED::GB::GB1182/DEL/2001 1 0 A PROCESSA61K--31/ The long ch COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1182/MUM/2007 1 0 PROCESS FA61K-9/16Process for WANBURY LIMITED::IN::IN1184/MUM/2004 1 0 A PROCESSA61K-37/00An improved ELDER PHARMACEUTICALS LTD::IN::IN1187/MUM/2006 1 0 PROCESS FA61K-31/7A process f
1195/CHE/2004 1 0 AN IMPROVA61-K 31/0A process PULLA REDM/S. NATCO PHARMA LTD::IN::IN1196/DEL/2001 1 0 A NOVEL 1A61K-31/4A novel l-a COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1197/DEL/1999 1 0 "A PROCESA61K-35/7A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1199/MUM/2010 1 0 A PROCESSA61K-9/08,Disclosed hJAVERI,UMAS.ZHAVERI PHARMAKEM PVT.LTD::IN::IN11/CHE/2004 1 0 A PROCESSA61K-9/00A process f J.S.S. MAHAVIDYAPEETHA::IN::IN1202/MUM/2001 1 0 A PROCESSA61-K 9/72The processBHATTACHAM/S. ALEMBIC LIMITED::IN::IN1203/MAS/1996 1 0 A PROCESSA61K-33/0We Claim: 1 M/S. TABLETS (INDIA)LIMITED::IN::IN1210/CHE/2007 1 0 OPTICALLYA61K-39/0The inventi MALLADI DRUGS & PHARMACEUTICALS LTD::IN::IN1210/DEL/2002 1 0 "A PROCESA61K-9/16The present NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)::IN::IN1211/MUM/2001 1 0 PROCESS FA61K-31/4A process f SUN PHARMACEUTICAL INDUSTRIES LTD.::IN::IN1212/DEL/1995 1 0 "A PROCESA61K-31/0A process fJOHN ROBENOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.::BM::BM1213/MUM/2003 1 0 A PROCESSA61-K 31/0A process f M/S. IPCA LABORATORIES LIMITED::IN::IN1215/CHE/2005 1 0 "AN IMPROA61K-31/0The improve SUVEN LIFE SCIENCES LTD::IN::IN1215/DEL/2004 1 0 "PROCESS A61K-31/0The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1215/MUM/2003 1 0 A PROCESSA61K-31/0 KUMAR, ASM/S. IPCA LABORATORIES LIMITED::IN::IN1215/MUM/2007 1 0 AN IMPROVA61K-31/7The present CLARIS LIFESCIENCES LTD.::IN::IN1215/MUM/2009 1 0 A PROCESSA61K-31/5The inventi1217/MUM/2005 1 0 PROCESS FA61K-21/0A process o CADILA HEALTHCARE LIMITED::IN::IN1223/DELNP/2004 1 0 "A PROCESA61K-9/20A dry blend PFIZER PRODUCTS INC.,::US::US1238/DEL/1999 1 0 AN IMPROVA61K-31/4All improve COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN123/MUM/2004 1 0 A PROCESSA61K-9/20Process forSAPTE VIN SAPTE VINAY RAMAKANT::IN::IN1242/KOLNP/2006 1 0 METHODS OA61K-47/3Methods of JOHNSON & JOHNSON VISION CARE, INC.::US::US1242/MUM/2004 1 0 ONE - POT A61K-31/6Disclosed h M/S. IPCA LABORATORIES LIMITED::IN::IN1243/MUM/2003 1 0 A MANUFACA61K-31/5A manufactuDHARMENDRSKYMAX LABORATORIES PVT LTD.::IN::IN1244/DELNP/2006 1 0 "A METHODA61K-31/3The present BAXTER INTERNATIONAL INC.::US::US1245/CHE/2006 1 0 IMPROVED A61K-31/5The present ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN1257/CHE/2007 1 0 AN IMPROVA61K-31/5The present AUROBINDO PHARMA LIMITED::IN::IN1258/DELNP/2005 1 0 "A PROCESA61K-31/2The present COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN1259/MUMNP/2006 1 0 A PROCESSA61K-31/1The present TEVA PHARMACEUTICAL INDUSTRIES LTD.::IL::IL1264/DEL/2002 1 0 "A PROCESA61K-031/The present RANBAXY LABORATORIES LIMITED::IN::IN1272/KOLNP/2004 1 0 DRY POWDEA61K- 9/72The present ASTELLAS PHARMA INC::JP::JP1275/CHENP/2006 1 0 A METHOD A61K-7/42The inventi BASF AKTIENGESELLSCHAFT::DE::DE1281/CHE/2007 1 0 IMPROVED A61K-31/0The present MYLAN LABORATORIES LTD.::IN::IN1284/CHE/2008 1 0 AN IMPROVA61K-31/0A method fo LAURUS LABS PVT LTD::IN::IN1287/DEL/1999 1 0 "A PROCESA61K-31/0A Process f COUNCIL OF SCEINTIFIC AND INDUSTRIAL RESEARCH::IN::IN1287/KOLNP/2006 1 0 A METHOD A61K-9/00,The present ALZA CORPORATION::US::US1290/KOLNP/2008 1 0 CATIONIC A61K- 9/00The present NOVAGALI PHARMA SA::FR::FR1290/MUM/2006 1 0 IMPROVED A61K-47/0The present ALEMBIC LIMITED::IN::IN1293/DELNP/2004 1 0 "A METHODA61K-47/4A 2-hydroxyKONSTANTIVIANEX S.A.::GR::GR1295/KOLNP/2009 1 0 METHODS OA61K- 31/4Novel metho MILLENNIUM PHARMACEUTICALS, INC.::US::US1297/DEL/1999 1 0 PROCESS FA61K-31/1A process f PANACEA BIOTEC LIMITED::IN::IN129/CHE/2004 1 0 IMPROVED A61K-31/1The inventi M/S. MALLADI DRUGS & PHARMACEUTICALS LTD::IN::IN1302/CHENP/2003 1 0 PROCESS FA61K-31/4Pure perind M/S. HETERO DRUGS LIMITED::IN::IN1309/DEL/2001 1 0 PROCESS FA61K-31/0A method fo COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH,::IN::IN1317/DEL/2008 1 0 IMPROVEDA61K-31/44The present JUBILANT ORGANOSYS LIMITED::IN::IN1321/MUM/2004 1 0 A PROCESSA61K-9/00A PROCESS F LUPIN LIMITED::IN::IN1322/CHE/2004 1 0 A PROCESSA61K-31/6The present AUROBINDO PHARMA LIMITED::IN::IN1322/DELNP/2008 1 0 ââ‚A61K-9/36Described h ABBOTT LABORATORIES GMBH::DE::DE
STUTI SRIVASTAVA::IN::INPRASHANT SHARMA::IN::INAJIT KUMAR HAZARIKA::IN::INJIBON C SARMA KATAKY::IN::IN
A process for the synthesis of 5-(N-ethyl-N-2-hydroxyethylamino)-2-pentylamine (Hydroxy Novoldamine), 5-(N,N-diethylamino)-2-pentylamine(Novoldamine) wherein the said process comprises a) ketalization of 1-chloro-4-pentanone carried out by treating it with glycol selected from ethylene glycol or neopentyl glycol in a molar ratio of 1:2 in presence of non polar organic solvent selected from toluene, cyclohexane, xylene, heptane and hexane and catalyst selected from para-toluene sulphonic acid, methane sulphonic acid, perchloric acid at temperature range of 80-140°C for 20-25 hours to obtain compound of formula (I) 2(3'-chloropropyl)2-methyl-1,3-dioxalane, 2-(3 '-chloropropyl) -2,5,5-Trimethyl 1,3-dioxane; 0) b) condensation of said compound of formula (I) 2(3'-chloropropyl)2-methyl- 1,3-dioxalane, 2-(3'-chIoropropyl) -2,5,5-Trimethyl 1,3-dioxane with substituted amine derivatives of formula (V) N-ethyl-N-2-hydroxy ethyl amine, N,N-diethylamine in a molar ratio of 2:5 in presence of non-polar solvents selected from toluene, xylene and cyclohexane at temperature ranging from 90°C-140°C for 18 hours to obtain compound of formula (II) 2-(3' -N-ethy 1- N-2-hydroxyethylaminopropyl)-2-methyl-1,3 -dioxalane (HNK Ketal); 3 H< 1 NR2 R1=R2=Ethyl or R1R2=Ethyl Rl=Ethyl; R1 =Ethyl R2=Hydroxy ethyl (11) (V) c) deprotection of the ketal group of compound of formula (II), 2-(3,-N-ethyI-N-2-hydroxyethylaminopropyl)-2-methyl-l,3-dioxalane (HNK Ketal) under acidic conditions at temperature range of 10- 50°C for 6-7 hours to obtain compound of formula (III) 5-(N-ethyl-N-2-hyd^xyethylamino)-4-pentanone or 5-(N.N-diethylamino)-4-pentanone; and 0 NT Ri = R2 = Ethyl (or) R1=Ethyl; R2=Hydroxy ethyl d) reductive amination of compound of formula (III), 5-(N-ethyl-N-2-hydroxyethylamino)-4-pentanone or 5-(N,N-diethylamino)-4-pentanone is carried out by treating it with alcoholic ammonia in presence of catalyst such as Raney Nickel under mild hydrogenation conditions such as 10-30 kg/cm2 and temperature ranging from 40-130°C for 2-5 hours to yield compound of formula (IV) namely 5-(N-ethyl-N-2-hydroxyethylamino)-2-pentylamine and 5-(N,N'diethyIamino)-2-pentylamine. 10 (IV) i)Ri ,R2= Ethylâ€â€Â>- 5-[N,N-diethylamino]-2-pentylamine] ii) R, = Ethyl, R2 = hydroxy ethyl â€â€Â*â– 5-[N-ethyl-N-2-hydroxyethylamino]-2-pent� �KALAWADIA RAMESH M::IN::INBOSE MILINA::IN::INBASAVARAJ K. NANJWADE::IN::INF. V. MANVI::IN::IN
BASAVARAJ K. NANJWADE::IN::INF. V. MANVI::IN::INKUMAR, RAJIV::IN::IN
AGARWAL VIRENDRA KUMAR::IN::INBRENDAN JOHN MURPHY::US::USBARBARA ALICE JOHNSON::US::USVILAS GAJANAN GAIKAR::IN::INGIRIJA RAMAN::IN::IN
FRANK MOLOCK::US::USAZAAM ALLI::US::KUMAR ASHOK::IN::INDalavi Dadaso Shankar::IN::IN
1324/KOL/2007 1 0 PROCESS FC11D-17/08A process f ITC LIMITED::IN::IN1325/DEL/1996 1 0 "PROCESS A61K-31/0The inventi ASTRA AKTIEBOLAG,::SE::SE1327/CHE/2008 1 0 SPACERLESA61K-47/0A method of INDIAN INSTITUTE OF TECHNOLOGY::IN::IN1331/CHENP/2005 1 0 METHOD FOA61K-9/28The inventi ROHM GMBH & CO. KG::DE::DE1334/KOLNP/2008 1 0 PROCESS FA61K-31/4The present SCINOPHARM SINGAPORE PTE, LTD.::SG::SG1336/CHENP/2005 1 0 METHOD OFA61K-9/28The inventi#N/A #N/A1337/MUMNP/2006 1 0 PROCESS FA61K-31/4An improved CIPLA LIMITED::IN::IN1338/CHENP/2005 1 0 METHOD FOA61K-9/28The inventi ROHM GMBH & CO. KG::DE::DE1339/DEL/2010 1 0 "A PROCESA61K-31/6The present DIRECTOR GENERAL, DEFENCE RESEARCH & DEVELOPMENT ORGANISATION.::IN::IN133/MUM/2001 1 0 AN IMPROVA61-K 35/7The inventi AJANTA PHARMA LIMITED::IN::IN1349/MUM/2005 1 0 NOVEL PROA61K-37/4Present inv WOCKHARDT LIMITED::IN::IN1350/MUM/2004 1 0 A NOVEL OA61K-31/4ABSTRACT A M/S. CIPLA LIMITED::IN::IN1354/DEL/2003 1 0 "ANTICOAGA61K-35/1Precipitate1355/CHE/2005 1 0 AN IMPROVA61K-9/00The present AUROBINDO PHARMA LIMITED::IN::IN1357/KOLNP/2003 1 0 A PROCESSA61K-9/16The inventi THE UNIVERSITY OF BRITISH COLUMBIA::CA::CA1357/MUM/2004 1 0 NOVEL SALA61K-31/0Disclosed h CIPLA LIMITED::IN::IN1360/MUM/2005 1 0 AN IMPROVA61K-31/4A process f ALEMBIC LIMITED::IN::IN1402/DEL/1999 1 0 "A PROCESA61K-31/7This invent COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1405/DEL/1999 1 0 "A PROCESA61K-7/48The inventi COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1419/DEL/2003 1 0 "PROCESS A61K-31/4A process fKEITH HOPASTRAZENECA UK LIMITED::GB::GB141/DEL/2003 1 0 "A PROCESA61K-31/0A process f PFIZER IRELAND PHARMACEUTICALS::IE::1420/CHE/2005 1 0 NOVEL PROA61K-31/0A novel pro MSN LABORATORIES LIMITED::IN::IN1427/DELNP/2003 1 0 "A PROCESA61K-9/16Atorvastati LEK PHARMACEUTICAL AND CHEMICAL COMPANY D.D.::SI::SI1431/CAL/1996 1 0 A METHOD A61K-9/06The inventi DR. GERHARD MANN CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH::DE::DE1436/DEL/1998 1 0 " A PROCE A61K-31/4A process f SCHERING AKTIENGESELLSCHAFT::DE::DE1451/DEL/1999 1 0 "A PROCESA61K-31/0A process f#N/A #N/A1454/MUMNP/2009 1 0 METHOD FOA01N- 25/2The inventi SOL-GEL TECHNOLOGIES LTD::IL::IL1479/MUM/2009 1 0 A PROCESSA61K-31/50The present EMCURE PHARMACEUTICALS LTD::IN::IN1481/CAL/1996 1 0 A PROCESSA61K-31/4Process for TIOGA PHARMACEUTICALS, INC.::US::US1485/DELNP/2005 1 0 "A METHOA61K-38/1The present INSTITUT PASTEUR AND INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE::FR::FR1486/CHE/2009 1 0 PROCESS FA61K-31/0The present1498/DEL/1997 1 0 "A PROCESA61K-31/4A process f FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y PHARMACEUTICOS, S.A., (FAES)::ES::ES149/MUMNP/2004 1 0 A PROCESSA61K-9/70A process oDR. SUSILOTROMMSDORFF GMBH & CO. KG ARZNEIMITTEL::DE::DE1509/MUM/2007 1 0 NOVEL PROA61K-31/4The method CENTAUR CHEMICALS PVT. LTD.::IN::IN1511/KOL/2008 1 0 A PROCESSA61K-36/0A new proceDUTTA AJOYDUTTA AJOY::IN::IN151/CHE/2003 1 0 AN IMPROVA61K-31/0The present ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN1528/MUM/2008 1 0 PROCESS FA23K-1/16,The present INDOCO REMEDIES LIMITED::IN::IN1529/CHE/2008 1 0 IMPROVED A61K-31/0The present NATCO PHARMA LIMITED::IN::IN1543/DELNP/2003 1 0 " APROCESA61K-31/4This invent OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIJU "RADA-PHARMA"::RU::RU1547/MUM/2005 1 0 PROCESS FA61K-31/00The present ALOK SAXENA::IN::IN1550/KOLNP/2005 1 0 A PROCESSA61K-9/70The inventi MONOSOLRX LLC::US::US1567/CHE/2007 1 0 A process A61K-35/7Nymphayol [1570/MUM/2005 1 0 INDUSTRIAA61K-31/4This invent EMCURE PHARAMACEUTICALS LTD.::IN::IN1592/CHE/2005 1 0 NOVEL META61K-31/6The present NATCO PHARAMA LIMITED::IN::IN1597/CHE/2006 1 0 PHARMACEUA61K-9/00The inventi MYLAN LABORATORIES LIMITED::IN::IN1601/KOLNP/2008 1 0 METHOD FOA61K-31/4Dermatitis MITSUBISHI TANABE PHARMA CORPORATION::JP::JP1604/DEL/1998 1 0 "A PROCESA61K-9/72A compositi CHIESI FARMACEUTICI S.P.A::IT::IT1616/KOLNP/2003 1 0 A PROCESSA61K-31/1A process o CEPHALON INC.::US::US
1616/MUM/2009 1 0 AN IMPROVA61K-47/3An improved#N/A SCITECH CENTRE::IN::IN1620/KOLNP/2005 1 0 PROCESS FA61K- 31/4The present TAKEDA PHARMACEUTICAL COMPANY LIMITED::JP::JP1622/KOLNP/2003 1 0 METHOD OFA61-K9/48,The inventi CSIR::ZA::ZA1638/MUM/2005 1 0 METHOD FOA61K-31/3A process f SAXENA ALOK::IN::IN163/KOL/2003 1 0 PROCESS FA61K-31/0Iron overloAMIT ROY AMIT ROY CHOWDHURY::IN::IN1649/DELNP/2005 1 0 "A METHODA61K-8/35A cream bas GALDERMA S.A.::CH::CH1666/MUM/2007 1 0 A PROCESSA61K-31/54A process f IPCA LABORATORIES LIMITED::IN::IN166/CHE/2006 1 0 MANUFACTUA61K-31/0The present NATCO PHARAMA LIMITED::IN::IN1677/KOLNP/2007 1 0 "A METHODA61K-/9/1 The present NORTON HEALTHCARE LIMITED::GB::GB167/MUM/2011 1 0 A PROCESSC07D-405/1The present CADILA HEALTHCARE LIMITED::IN::IN1694/DELNP/2003 1 0 "A METHODA61K-9/28The presentCHO, KYU-ISUMSUNG FINE CHEMICALS CO. LTD.,::KR::KR1698/CHENP/2005 1 0 METHOD FOA61K-09/1The inventi ROHM GmbH & CO. KG::DE::DE1705/DELNP/2004 1 0 "A PROCESA61K-31/4A process f TEVA PHARMACEUTICAL INDUSTRIES, LTD.::IL::IL1707/DEL/1996 1 0 "PROCESS FA61K-31/4The inventi PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./ S.A.::IE::1707/KOLNP/2008 1 0 METHOD FOA61K- 9/08The inventi WYETH::US::US1710/DEL/1996 1 0 "A PROCESA61-K 7/50CompositionAMRIT MANCOLGATE-PALMOLIVE COMPANY::US::US1711/DEL/2005 1 0 "A METHODA61K-7/42A method of CRODA INTERNATIONAL PLC,::GB::GB1712/DEL/1997 1 0 "A PROCESA61K-31/1The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN172/DEL/1997 1 0 "A PROCESA61K-35/71. A proces NATIONAL INSTITUTE OF IMMUNOLOGY::IN::IN172/DEL/2002 1 0 A PROCESSA61K-9/10The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH,::IN::IN1730/KOLNP/2005 1 0 A PROCESSA61K-35/7A process fNOWICKY, NOWICKY, WASSYL::AT::AT1730/KOLNP/2006 1 0 A PROCESSA61K-9/00Disclosed a GENZYME CORPORATION::US::US1734/KOL/2007 1 0 A PROCESSA61K-33/2ConventionaMAITY PRASMAITY PRASANTA::IN::IN1734/MUMNP/2009 1 0 PROCESS FC07H- 19/1The present CAN-FITE BIOPHARMA LTD::IL::IL1747/MUM/2007 1 0 PROCESS FA61K-9/20,The present MACLEODS PHARMACEUTICALS LIMITED::IN::IN174/MUM/2004 1 0 PROCESS FA61K-31/1The present M/S. IPCA LABORATORIES LIMITED::IN::IN1754/CHENP/2003 1 0 A METHOD A61-K 35/11754/CHENP/SUKAVANES176/DELNP/2007 1 0 "PROCESS A61K-33/4A process f INNOPHOS, INC.::US::US1771/DEL/1998 1 0 "AN PROCEA61K-9/22A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1776/MUM/2007 1 0 AN IMPROVA61K-35/38The present USV LIMITED::IN::IN1781/CHENP/2005 1 0 A METHOD A61K-49/2Method for BRACCO INTERNATIONAL B.V::NL::NL1784/CHE/2005 1 0 "PROCESS A61K-31/5Processes fMITRA,PUCHMITRA,PUCHALAPALLI::IN::IN179/MUM/2008 1 0 PROCESS FA61K-31/7The present PFIZER PRODUCTS INC.::US::US180/DELNP/2004 1 0 "A PROCESA61K-31/4In the pres TAS SINAN::TR::TR1810/DELNP/2007 1 0 "DIAGNOS A61K-51/0The inventi1818/CHE/2005 1 0 AN IMPROVA61K-31/4Title of th MSN LABORATORIES LIMITED::IN::IN1840/MUMNP/2010 1 0 IMPROVED A61K-9/20The inventi SUEDZUCKER AKTIENGESELLSCHAFT MANNHEIM/PCHSENFURT::DE::DE184/CHENP/2005 1 0 A PROCESSA61K-31/5The inventi KRKA, D.D., NOVO MESTO::SI::SI1850/CHENP/2005 1 0 A CONTINUA61K-9/16This invent1861/CHENP/2004 1 0 A PROCESSA61K-09/3The present ROHM GMBH & CO. KG::DE::DE1862/MUM/2010 1 0 PROCESS FA61K-31/0Disclosed h HARMAN FINOCHEM LIMITED::IN::IN1863/KOLNP/2004 1 0 #N/A #N/A #N/A #N/A #N/A1867/CAL/1998 1 0 ACIDIC CO A61-K9/46acidic comp GERHARD GERGELY.::AU::AU1869/CHE/2006 1 0 A PROCESSA61K-9/20Present inv MYLAN LABORATORIES LIMITED::IN::IN186/KOL/2009 1 0 A PROCESSA61K-8/00A process f NATIONAL ALUMINIUM COMPANY LIMITED::IN::IN1870/CHENP/2006 1 0 NEW PROCEA61K-31/2The inventi BASILEA PHARMACEUTICA AG::CH::CH1887/DEL/1997 1 0 " A PROCE A61K-31/0A process f RHONE -POULENC RORER S.A.::FR::FR188/CHE/2005 1 0 "AN IMPROA61K-031/An improved AUROBINDO PHARMA LIMITED::IN::IN
MEIER, Christian::DE::DEGRYCZKE, Andreas::DE::DERAMY LIDOR-HADAS::IL::ILETI KOVALEVSKI-ISHAI,::IL::ILALAN JOHN PETTMAN::GB::GBJULIE ANN HARRISON::GB::GBZERFAS, JULIE::US::USWEBB, CHANDRA A::US::US
ELLIS JAMES MORGAN HUNTER::GB::BEATTIE ROGER, JAMES::GB::AHMED KAMAL::IN::INNIMMA GADDA LAKSHMI GAYATRI::IN::INANITA KAMRA::IN::INSUMAN DHAWAN::IN::INVICTOR JOHN SUNDAR::IN::INRAJADAS JAYAKUMAR::IN::IN
LESHCHINER ADELYA K.::US::USKONOWICZ PAUL A.::US::US
IRMGARD GERGELY::AT::ATTHOMAS GERGELY::AT::ATDR, GORANTLA SEETA RAMANJANEYULU::IN::INDR. OM DUTT TYAGI::IN::INP. V. RAMANA MURTHY::IN::INB. W. HARRY::IN::INHILPERT, Hans::CH::CHHEBEISEN, Paul::CH::CHERIC DIDIER::FR::FRPASCAL PECQUET::FR::FRPATHURI SREENIVASA RAO::IN::INMEENAKSHISUNDERAM SIVAKUMARAN::IN::IN
1890/CHE/2007 1 0 PROCESS FC07D-477/0Abstract T HOSPIRA, INC.::US::US1891/DELNP/2005 1 0 "A METHODA61K-31/3Natural andDAVID TERMAGNACHEM INTERNATIONAL LABORTORIES,INC.,::US::US1892/MUM/2007 1 0 A PROCESSA61K-31/7The deliver CLARIS LIFESCIENCES LIMITED::IN::IN1893/MUM/2006 1 0 PROCESS FA61K-31/7The present EMCURE PHARMACEUTICALS LTD.::IN::IN1899/KOLNP/2006 1 0 A METHOD A61K- 47/4A naturally190/DEL/2001 1 0 "A PROCESA61K-31/5The present RANBAXY LABORATORIES LIMITED::IN::IN1920/DELNP/2008 1 0 METHOD OFA61K-9/16Methods areOBERG, KeitMANNKIND CORPORATION::US::US1920/DEL/2005 1 0 "PROCESS A61K-31/4The present IND-SWIFT LABORATORIES LIMITED::IN::IN1921/DELNP/2008 1 0 METHOD OFA61K-9/16Methods are MANNKIND CORPORATION::US::US1924/MUM/2008 1 0 A PROCESSA61K-31/55The present CADILA HEALTHCARE LIMITED::IN::IN1927/DELNP/2003 1 0 "A PROCESA61K-31/0The use of ROBERT F. ARES TRADING S.A.,::CA::CA1930/MUM/2008 1 0 PROCESS FA61K-31/34The present IPCA LABORATORIES LIMITED::IN::IN1945/MUMNP/2011 1 0 "METHOD FA61K- 31/5Preparation ZHEJIANG CHARIOTEER PHARMACEUTICAL CO., LTD.::CN::CN1947/DELNP/2003 1 0 "METHOD OA61K-9/00A method of ALEXZA PHARMACEUTICALS, INC.::US::US1952/CHENP/2006 1 0 A PROCESSA61K-7/42,Abstract ThBERG-SCHULDSM IP ASSETS B.V.::NL::NL1967/MAS/1998 1 0 AN ENZYMEA61K-35/7A method fo THE RICEX COMPANY::US::US196/CHE/2006 1 0 AN IMPROVA61K-31/0The present AUROBINDO PHARMA LIMITED::IN::IN196/DEL/2000 1 0 "A PROCESA61K-31/0The present RANBAXY LABORATORIES LIMITED::IN::IN196/DEL/2003 1 0 "A NOVEL A61K-35/7'The presen COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN1977/CHENP/2003 1 0 A METHOD A61K-51/0A methof foFAULK, W. FAULK PHARMACEUTICALS, INC::US::US1979/DELNP/2006 1 0 "A PROCESA61K-31/4A process f BRISTOL-MYERS SQUIBB COMPANY::US::US2002/CHENP/2008 1 0 "A PROCESA61K-9/16A process fSHERRY, R RECKITT BENCKISER HEALTHCARE (UK) LIMITED::GB::GB201/DEL/2001 1 0 "A PROCESA61K-35/1The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2021/DEL/2004 1 0 A SIMPLIF A61K-35/7The presentBIKRAM SINCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2025/MUMNP/2010 1 0 PROCESS FA61K-31/44The present CIPLA LIMITED::IN::IN2041/DELNP/2005 1 0 "METHOD OA61K-9/12The inventi NEOPHARM, INC.::US::US2049/DEL/1996 1 0 "A PROCESA61K-007/A process f KAO CORPORATION::JP::JP2054/CAL/1996 1 0 A PROCESSA61K-31/0A protected NIPPON KAYAKU KABUSHIKI KAISHA::JP::JP2057/DEL/2004 1 0 "NOVEL SUA61K-31/3Novel substCHANDAN SCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2069/MUM/2007 1 0 AN IMPROVA61K-9/20An improved CENTAUR CHEMICALS PVT. LTD.::IN::IN2078/DEL/2006 1 0 A PROCESSA61K-35/7This invent DIRECTOR GENERAL,MINISTRY OF DEFENCE, DEFENCE RESEARSH & DEVELOPMENT ORGANIZATION::IN::IN207/DEL/2002 1 0 "PROCESS A61K-31/0Disclosed iDR.(MRS) M/S. IND-SWIFT LIMITED::IN::IN2087/DEL/1998 1 0 " A PROCE A61K-31/0A method fo SMITHKLINE BEECHAM PLC::GB::2093/MUM/2008 1 0 A PROCESSA61K-9/00The inventi INDIAN INSTITUTE OF TECHNOLOGY, BOMBAY::IN::IN20/MUMNP/2009 1 0 METHODS FA61K-9/51A method f ICEUTICA PTY LTD::AU::AU2114/MAS/1998 1 0 A METHOD A61K-35/7The present M/S. RECKITT BENCKISER (UK) LIMITED::GB::212/CHE/2004 1 0 A METHOD A61K-31/0A METHOD FMUHAMMED #N/A2133/DEL/1997 1 0 A PROCESSA61K-31/0A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2138/KOLNP/2005 1 0 A METHOD A61K-31/4The inventi ACADIA PHARMACEUTICALS INC.::US::US213/DEL/2001 1 0 "A Process C07-D -A 6The present Council of Scientific and Industrial Research,::IN::IN2140/DEL/1997 1 0 "A PROCESA61K-31/0A process f SAMJIN PHARMACEUTICAL CO. LTD.,::KR::KR2142/DELNP/2004 1 0 "A PROCESA61K-9/16A process f PFIZER PRODUCTS INC::US::US2149/DEL/1998 1 0 "AN IMPROA61K-31/8The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2152/DEL/2004 1 0 "A PROCESA61K-35/7The inventi INDIAN COUNCIL OF AGRICULTURAL RESEARCH::IN::IN2153/DEL/1998 1 0 "AN IMPROA61K-31/0An improve COUNCIL OF SCEINTIFIC AND INDUSTRIAL RESEARCH::IN::IN2153/MUMNP/2007 1 0 ENDOXIFE A61K-31/3The present JINA PHARMACEUTICALS INC.::US::US2159/MUM/2006 1 0 A COMPOSIA61K-35/00A pharmaceu2167/MUMNP/2011 1 0 SWOLLEN SA61K- 8/89There is pr MOMENTIVE PERFORMANCE MATERIALS, INC.::US::US
POESTGES, REINER::DE::DEAMMER, RICHARD::DE::DERAJAGOPAL THIRUVENGADAM::IN::INSHAIK MADHU SUHAN,::IN::INHAROLD MONRO MOODY::NL::NLJOHANNA CHRISTINA MARIA SMEETS::NL::P. R. HARI::IN::INWILLI PAUL::IN::IN
P. R. HARI::IN::INWILLI PAUL::IN::INJASTI VENKATESWARLU::IN::IN
DESHPANDE AMOL DINKAR::IN::IN
LOTANKAR, PRASHANT AJIT::IN::INDEVADIGA, VIDYA RAMA::IN::INGILLIAN ELIZABETH SMITH::GB::JOHN BRYCE STRACHAN::GB::CARUSO, FRANK::AU::AUCAMMARANO, RAFFAELE::AU::AUDILIP MEHTA::IN::INANSELM DE SOUZA::IN::INDR. SONAL I. THAKORE::IN::INMR. MAYUR VALODKAR::IN::IN
DR. SONAL I. THAKORE::IN::INMR. MAYUR VALODKAR::IN::INVISKOV CHRISTIAN::FR::FR
PRAKASH ANAND::IN::INAGARWAL ASHUTOSH::IN::INRAO, DHARMARAJ RAMACHANDRA::IN::INKANKAN RAJENDRA, NARAYANRAO::IN::INERICH P. LERCHENFELD::US::USDONALD E. STRIEGEL::US::USMARTINA MUTTER::DE::DEMARK SCHMITZ::DE::DE
247/DEL/2005 1 0 "PROCESS A61K-31/1Process for LES LABORATOIRES SERVIER::FR::FR247/DEL/2008 1 0 METHOD OFA61K-9/16,Disclosed i CJ CHEILJEDANG CORPORATION::KR::KR2481/MUM/2008 1 0 PREPARATIA61K-31/38Disclosed h INDOCO REMEDIES LIMITED::IN::IN2488/DELNP/2004 1 0 "A PROCESA61K-31/5The inventi ASTRAZENECA AB::SE::SE2492/CHE/2009 1 0 "PROCESS C07D-411/0The present MYLAN LABORATORIES LTD::IN::IN2498/DELNP/2004 1 0 HEPATOPROA61K-31/3A method f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2498/DELNP/2005 1 0 "A PROCESA61K-9/16The inventi24/KOL/2004 1 0 "A PROCESA61-K 9/00The presentVYAS SHARTORRENT PHARMACEUTICALS LTD.::IN::IN251/MUMNP/2004 1 0 A PROCESSA61K-31/4A process fKELLY NIC ACADIA PHARMACEUTICALS INC.::US::US253/CHE/2003 1 0 A PROCESSA61K-9/00The present DR. REDDY'S LABORATORIES LIMITED::IN::IN2562/DELNP/2004 1 0 A PROCESSA61K-31/3The present COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN2565/DELNP/2004 1 0 A PROCESSA61K-35/7The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2576/DELNP/2004 1 0 "A METHODA61K-9/14The inventi BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG.::DE::DE2578/DELNP/2007 1 0 " PROCESS A61K-33/0The inventiDENISE FAYIPSEN PHARMA S.A.S.,::FR::FR257/DEL/2003 1 0 "A PROCESA61K-35/7The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2595/DEL/1997 1 0 "A PROCESA61K-31/0A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2596/DEL/1997 1 0 "A PROCESA61K-009/A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN259/DEL/2003 1 0 "A PROCESA61K-31/1A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2600/DELNP/2004 1 0 "SUSPENSIA61K-9/12SuspensionCHRISTEL BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG.::DE::DE2602/DELNP/2007 1 0 "STABLE F A61K-38/2Stable pha NOVO NORDISK A/S::DK::DK260/DEL/2003 1 0 A PROCESSA61K-31/0A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2610/DELNP/2004 1 0 PROCESS FA61K-35/7The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2612/CHE/2010 1 0 PROCESS FC07D- 209/Present inv DIVI'S LABORATORIES LTD.,::IN::IN2636/MUM/2011 1 0 AN IMPROVA61K-9/00The present WOCKHARDT LIMITED::IN::IN2639/CHENP/2004 1 0 A PHARMACA61K-48/0This invent2639/DEL/2007 1 0 AN IMPROVA61K-31/0The inventiDEVI PRASACOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN2642/DELNP/2006 1 0 "METHOD FA61K-31/2Disclosed iSALAMA ,ZORIEMSER ARZNEIMITTEL AG.::DE::DE2644/DELNP/2006 1 0 "PROCESS A61K-9/20A Process fKLAUS BENKBAYER PHARMA AKTIENGESELLSCHAFT,::DE::DE264/DEL/2001 1 0 "AN IMPROA61K-31/0The present RANBAXY LABORATORIES LIMITED::IN::IN264/KOL/2003 1 0 ENROBED A61K- 9/20An enrobed BUNICK FRAMCNEIL-PPC, INC.::US::US2666/DEL/2005 1 0 "A PROCESA61K-9/20A process f LIFECARE INNOVATIONS PVT. LTD.::IN::IN2669/DEL/2006 1 0 "A PROCESA61K-31/57A process f LIFECARE INNOVATIONS PVT. LTD.::IN::IN266/CHE/2003 1 0 PROCESS FA61K-047/The RasayanMr. P.R. M/S. THE ARYA VAIDYA PHARMACY (COIMBATORE)LIMITED::IN::IN266/MAS/2003 1 0 #N/A #N/A #N/A #N/A #N/A267/DEL/2003 1 0 "A PROCESA61K-9/20The present NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)::IN::IN2683/DEL/2006 1 0 AN IMPROVA61K-31/38The present COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN268/KOL/2003 1 0 METHOD FOA61- K 31/There is di GANGA RAJUINTERHEALTH NUTRACEUTICALS INCORPORATED::US::US2695/DEL/2005 1 0 A PROCESSA61K-9/10The object 269/CAL/2002 1 0 A PROCESSA61K-9/08A process fSHARMA DR DABUR PHARMA LIMITED::IN::IN2709/DEL/2005 1 0 "A PROCESA61K-31/4Celecoxib i NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH::IN::IN270/KOLNP/2003 1 0 A METHOD A61K-9/00A method of CHIRON CORPORATION::US::US271/DELNP/2003 1 0 "A PROCESA61K-47/1The presentDUDLEY RO271/MUM/2005 1 0 AN IMPROVA61K-31/4Disclosed h IPCA LABORATORIES LTD.::IN::IN2728/KOLNP/2007 1 0 A PROCESSA61K-9/20The inventi #N/A2729/KOLNP/2007 1 0 A PROCESSA61K-9/20A process f #N/A277/MUMNP/2003 1 0 METHOD OFA61K-9/14A method of CHR. HANSEN, INC.::US::US2793/DEL/1997 1 0 "A PROCESA61K-35/7A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN27/CHE/2005 1 0 IMPROVED A61K-031/The present ORCHID CHEMICALS & PHARAMACEUTICALS LTD::IN::IN
KAUSTUBH R. TAMBWEKAR::IN::INCHAMAN LAL KAUL::IN::INCHAUDHARI RAGHUNATH VITTHAL::IN::INBHIDE SUNIL RAMACHANDRA::IN::IN
MADAN, DR. ANIL KUMAR::IN::INGUPTA, VISHAL::IN::IN
MADAN, DR. ANIL KUMAR::IN::INGUPTA, VISHAL::IN::IN
GARIMA CHAWLA::IN::INARVIND KUMAR BANSAL::IN::INULMER JEFFREY::US::USDUBENSKY THOMAS W JR.::US::USUNIMED PHARMACEUTICALS LLC.,::US::US
LABORATOIRS BESINS INTERNATIONAL, SAS::FR::FRDHURANDHARE VIJAY::IN::INDALAVI DADASO SHANKAR::IN::INASHWORTH, JUDY::DE::DEARKENAU-MARIC, ELISABETH::DE::DEBARTHOLOMAUS, JOHANNES::DE::DEARKENAU-MARIC, ELISABETH::DE::DEGAYSER CHARLES W JR::US::USGOYETTE, JEAN PAUL::US::USSATINDER MOHAN JAIN::IN::INRANDHIR SINGH KAPIL::IN::INSINGARAVEL MOHAN::IN::INKANAGARAJ SURESH KUMAR::IN::IN
2810/DEL/1996 1 0 "A PROCESA61K-31/0A process f BIOCHEM PHARMA INC.::CA::CA281/DELNP/2005 1 0 " A PHARMA61K-38/5The present HELIX BIOPHARMA CORP.::CA::CA2833/CHENP/2005 1 0 A CRYSTALA61K-31/4ABSTRACT A 2864/CHE/2007 1 0 IMPROVED A61K-31/3The present NEULAND LABORATORIES LIMITED::IN::IN2871/DELNP/2004 1 0 PROCESS FA61K-31/4A process f PHARMACIA CORPORATION::US::US2875/DEL/1998 1 0 " AN IMPR A61K-33/0An improved COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH,::IN::IN2889/DELNP/2005 1 0 " DRY POWA61K-9/72The present OTSUKA PHARMACEUTICAL CO., LTD.,::JP::JP288/MUM/2003 1 0 A NOVEL PA61K-9/00A process f M/S BAKUL FINECHEM RESEARCH CENTRE::IN::IN2893/DEL/1996 1 0 "PROCESS A61K-31/0A process f RHONE-POULENC RORER S.A.::FR::FR289/DEL/2000 1 0 "PROCESS A61K-31/0A process f PANACEA BIOTEC LIMITED::IN::IN2929/DELNP/2004 1 0 A PROCESSA61K-31/4A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN292/MUM/2007 1 0 PROCESS FA61K-31/44The present IPCA LABORATORIES LIMITED::IN::IN2933/DEL/1997 1 0 "A PROCESA61K-9/14A powdered,2938/KOLNP/2011 1 0 SYNTHESISA61K-47/4The present CREABILIS S. A.::LU::LU2942/DEL/1997 1 0 "AN IMPROA61K-31/0An improved COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN2945/DEL/1997 1 0 "AN IMPROA61K-31/0An improved2946/DEL/1997 1 0 "AN IMPROA61K-31/0An improved COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN294/CHE/2004 1 0 PROCESS FA61K-31/4The present ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN2981/KOLNP/2008 1 0 A PHARMACC12N- 1/20The inventi ORGANOBALANCE GMBH::DE::DE29/CHE/2003 1 0 NOVEL PROA61K-31/4The inventi M/S. NATCO PHARMA LTD::IN::IN300/KOL/2005 1 0 A PROCESSA61K-31/4The present WYETH::US::US3010/CHE/2009 1 0 METHOD OFC07D- 211/A novel aq R L FINE CHEM::IN::IN3016/DELNP/2004 1 0 "A METHODA61K-9/48A method of FMC BIOPOLYMER AS::NO::NO301/MUMNP/2003 1 0 A METHOD A61-K 9/00A method fo ASTRAZENECA AB::SE::SE3041/CHENP/2005 1 0 USE OF B7 A61K-38/0"USE OF B7 WYETH::US::US3053/CHENP/2007 1 0 ORALLY DI A61K-9/20A process f AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A::IT::IT305/DEL/2003 1 0 A PROCESSA61K-31/0This invent COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN3061/KOLNP/2006 1 0 PROCESS AA61K-31/5There is pr REDX PHARMA LIMITED::GB::GB3065/DEL/1998 1 0 "A PROCESA61K-35/0A process f COUNCIL OF SCEINTIFIC AND INDUSTRIAL RESEARCH::IN::IN306/DELNP/2009 1 0 "A COMPOSA61K-31/3This invent MARS INCORPORATED::US::US3071/DEL/2005 1 0 "A PROCESA61K-31/6The present THE DIRECTOR GENERAL, DEFENCE RESEARCH & DEVELOPMENT ORGANISATION (DRDO)::IN::IN309/DEL/2004 1 0 "A PROCESA61K-9/00The instant SBL PRIVATE LIMITED::IN::IN3115/CHENP/2004 1 0 PREPARATIA61K-51/0"PREPARATI UNIVERSITY OF ZURICH::CH::CH311/CAL/2002 1 0 A PROCESSA61K-35/7This invent KONTEST CHEMICALS LTD.::IN::IN3133/DEL/1997 1 0 "A COMPOUA61K-31/3A method of WARJNER-LAMBERT COMPANY::US::US3149/DELNP/2007 1 0 "ÃÅÂA̧61K-31/7This invent315/MUM/2003 1 0 A PROCESSA61-K 9/20A process f ALKEM LABORATORIES LTD.::IN::IN315/MUM/2007 1 0 PROCESS FA61K-31/20The present IPCA LABORATORIES LIMITED::IN::IN3163/DELNP/2007 1 0 PROCESS FA61K-31/6This invent HOFFMANN-LA ROCHE AG::CH::CH3169/CHENP/2004 1 0 A PROCESSA61K-31/5The present CIBA SPECIALTY CHEMICALS HOLDING INC::CH::CH316/MUM/2003 1 0 A NOVEL PA61-K 9/14A process f ALKEM LABORATORIES LTD.::IN::IN3197/CHENP/2005 1 0 "A NUTRITA61K-31/3This invent RATH, MATTHIAS::ZA::3219/DELNP/2005 1 0 "CERAMIC A61K-9/14The present321/DEL/2000 1 0 A PROCESSA61K-031/A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH,::IN::IN3228/CHENP/2004 1 0 TRIAZOLE- A61K-31/4The presentLANGE, JosM/S. SOLVAY PHARMACEUTICALS B.V::NL::NL323/DEL/2001 1 0 AN IMPROVA61K-31/0The inventi COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN3252/DELNP/2007 1 0 "METHOD OA61K-9/00The inventiKURT HEINPANTEC AG::CH::CH326/MUM/2002 1 0 A PROCESSA61K-9/16The presentSANDIP B. CADILA HEALTHCARE LIMITED::IN::IN
ALEX CIMPOIA::CA::CAKRZYSTOF BEDNARSKI::CA::CADICKSTEIN JODI::CA::CACHAO, HEMAN::CA::CANINGAM SRINIVASA REDDY::IN::INMANNE SATYANARAYANA REDDY::IN::IN
DR. REDDY'S LABORATORIES LIMITED::IN::INDR. REDDY'S LABORATORIES INC.::US::USBATHINI GURUSWAMY::IN::IN
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK::US::USHEALTH RESEARCH, INC.,::US::USANNAPURNA JETTY::IN::IN
DATTATRAY MANOHAR AKKEWAR::IN::IN
VISHNU LAL SHARMA::IN::INSUPRABHAT RAY::IN::IN
327/MAS/2000 1 0 A PROCESSA61K-35/7The present M/S. BIOCON LIMITED::IN::IN328/CHE/2003 1 0 PROCESS FA61K-31/4The present MATRIX LABORATORIES LTD::IN::IN328/DEL/2002 1 0 A PROCESSA61K-9/08A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN3297/CHENP/2006 1 0 A SUBSTI A61K-31/5The present H.LUNDBECK A/S::DK::DK32/DEL/2003 1 0 THE PROCEA61K-031/This invent UNIVERSITY OF DELHI::IN::IN3329/MUM/2010 1 0 LIPIDIC N A61K-47/48The oral so335/DEL/2002 1 0 "A PROCESA61K-31/0A process f COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN335/MUM/2003 1 0 AN IMPROVA61K-31/4An improved M/S. IPCA LABORATORIES LTD.::IN::IN336/DEL/2003 1 0 "METHOD FA61K-7/34A process f NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)::IN::IN337/DEL/2003 1 0 "AN IMPROA61K-31/0The present NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)::IN::IN337/MUM/2002 1 0 A PROCESSA61K-31/2A process ALEMBIC LIMITED::IN::IN338/DEL/2003 1 0 "A PROCESA61K-31/5The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN3403/CHENP/2008 1 0 PROCESS FA61K-31/3Abstract PR BASILEA PHARMACEUTICA AG::CH::CH3427/DEL/1998 1 0 "A PROCESA61K-31/3A process f JUBILANT ORGANOSYS LTD.::IN::IN3437/CHENP/2005 1 0 OIL EMULSA61K-9/10The inventi B BRAUN MELSUNGEN AG::DE::DE3446/DELNP/2004 1 0 "A COATEDA61K-9/16The inventi ETHYPHARM::FR::FR3462/DEL/2005 1 0 NOVEL SUPA61K-15/6Novel super INDIAN COUNCIL OF AGRICULTURAL RESEARCH::IN::IN3471/CHENP/2006 1 0 MICRONIZAA61K-9/14A process f NOVARTIS AG::CH::CH3483/DEL/1997 1 0 "A PROCESA61K-49/0The N-demetDOUGLAS D.ZILA, INC.::US::US3506/CHENP/2005 1 0 A PHARMACA61K-31/4The present H. LUNDBECK A/S::DK::DK3530/KOLNP/2009 1 0 METHOD FOC07D-309/2A method fo DAIICHI SANKYO COMPANY, LIMITED::JP::JP3558/DELNP/2004 1 0 "METHOD FA61K-9/14A method fo MITSUBISHI CHEMICAL CORPORATION::JP::JP355/KOLNP/2007 1 0 LYSIS/RES A61P- 35/0Lysis/reseaGODFRIN, YERYTECH PHARMA::FR::FR355/MUM/2002 1 0 A PROCESSA61-K 31/4A process o USV LIMITED::IN::IN357/MUM/2002 1 0 PROCESS FA61K-31/138 CONSTANTIPFIZER PRODUCTS INC::US::US358/DEL/1998 1 0 "AN IMPROA61K-31/0An improved CHIEF CONTROLLER OF RESEARCH AND DEVELOPMENT, MINISTRY OF DEFENCE, GOVERNMENT OF INDIA::IN::IN360/KOLNP/2007 1 0 A PROCESSA61K-47/4There is di CHIESI FARMACEUTICI S.P.A.::IT::IT3679/CHENP/2006 1 0 SUNSCREENA61K-8/02The present BASF AKTIENGESELLSCHAFT::DE::DE369/CHE/2010 1 0 A THIN FI A61K-9/00The present36/DEL/2004 1 0 "PROCESS A61K-31/0Process for RANBAXY LABORATORIES LIMITED::IN::IN370/MUM/2005 1 0 A PROCES A61K-31/2A process f LUPIN LIMITED::IN::IN3719/CHENP/2006 1 0 METHOD OFA61K-8/46R1 and R2 e CIBA HOLDING INC.::CH::CH3727/DEL/1998 1 0 "A PROCESA61K-49/0The N-demetDOUGLAS DZILA BIOTECHNOLOGY, INC.::US::US3741/DELNP/2008 1 0 "USE OF O A61K-45/0The inventi NTNU TECHNOLOGY TRANSFER AS::NO::NO3748/KOLNP/2006 1 0 "HEAT STE A61K-9/00,The present NORTON HEALTHCARE ,LTD.,::GB::GB374/DEL/2001 1 0 '' AN IMP A61K-31/0The present RANBAXY LABORATORIES LIMITED,::IN::IN374/MUM/2004 1 0 A PROCESSA61K-31/0A process M/S. IPCA LABORATORIES LIMITED::IN::IN375/DEL/2001 1 0 "A PROCESA61K-31/0The present RANBAXY LABORATORIES LIMITED::IN::IN3769/KOLNP/2008 1 0 METHODS FA61K- 9/00Ophthalmic JOHNSON & JOHNSON VISION CARE, INC.::US::US376/CHE/2003 1 0 PREPARATIA61K-31/7A process 3771/DEL/1998 1 0 A PROCESSA61K-31/3A hydrate o SMITHKLINE BEECHAM P.L.C.,::GB::GB377/CHE/2003 1 0 A COMPOSIA61K-31/5The invemti377/DEL/2002 1 0 A compositiA61K-31/0A process h Council of Scientific and Industrial Research::IN::IN3781/DEL/1998 1 0 "A PROCESA61K-9/20"A PROCESS SMITHKLINE BEECHAM CORPORATION::US::US378/CHENP/2005 1 0 MAKE-UP CA61K-8/89The inventi LVMH RECHERCHE::FR::FR3794/DELNP/2004 1 0 "A PROCESA61K-9/00The present LTS LOHMANN THERAPIE-SYSTEME AG::DE::DE37/CHENP/2004 1 0 TREATMENTA61K-39/3This invent M/S. APHTON CORPORATION::US::US37/MUM/2001 1 0 PROCESS FA61K-9/58The present SUN PHARAMACEUTICAL INDUSTRIES LTD::IN::IN
Kondapuram Vijaya Raghavan::IN::INGOPADI M. VENKATESH::US::UNAGESWARA R. PALEPU::GB::SGOUAISBAULT, Rosemary::FR::FRFAURE-TROMEUR, Melanie::FR::FRSEIBERTZ, FRANK::DE::DEKRUMME, MARKUS::DE::DEGRIMES, Stephen::US::USGEVAS, Philip, C.::US::USGANORKAR KIRTI WARDHAMAN::IN::INKHANNA SATISH::CH::CH
3826/DELNP/2004 1 0 "A PROCESA61K-41/0The presentWHYTE, SUCHEMSTOP PTY. LTD::AU::AU3828/DELNP/2006 1 0 "A PROVESA61K-31/5"A PROCESS TEVA PHARMACEUTICAL INDUSTRIES LTD.::IL::IL383/CHE/2004 1 0 AN IMPROVA61K-31/7The presentBUDIDET SAUROBINDO PHARMA LIMITED::IN::IN3851/DELNP/2005 1 0 "PROCESS A61K-9/20Process for DSM IP ASSETS B.V::NL::NL387/CHE/2005 1 0 A NOVEL PA61K-35/0ABSTRACT A R.L. FINE CHEM::IN::IN387/KOL/2003 1 0 A PROESS A61K-31/2A process fDR. SWAPADR. SWAPAN KUMAR CHATTERJEE::IN::IN387/MUM/2008 1 0 ONE POT PA61K-47/0Disclosed h FDC LIMITED::IN::IN389/CHE/2004 1 0 A PROCESSA61K-07/0The present SAMI LABS LIMITED::IN::IN3909/DELNP/2007 1 0 "REVERSE A61K-9/10The presentMAUREL JEMEDESIS PHARMA::FR::FR3956/DELNP/2004 1 0 "A PROCESA61K-47/4A process oCAPOCCHI, CHIESI FARMACEUTICI S.P.A::IT::IT396/CHE/2005 1 0 AN IMPROVA61K-31/5The present ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN399/MAS/2002 1 0 PROCESS FA61K-33/4A present i DR. REDDY'S LABORATORIES LTD.::IN::IN3/MUMNP/2007 1 0 PROCESS FA61K-9/20,The inventi R P SCHERER TECHNOLOGIES,INC::US::US401/MUM/2008 1 0 PROCESS FC07D-241/0The present CADILA HEALTHCARE LIMITED::IN::IN4028/DELNP/2009 1 0 ââ‚A61K-9/00The present SANTEN SAS::FR::FR402/MUMNP/2003 1 0 A PROCESSC07H-13/06 HINDUSTAN LEVER LIMITED::IN::IN402/MUM/2003 1 0 A PROCESSA61K-31/4We claim: 1PANDEY, BI4031/DELNP/2005 1 0 "METHODS A61K-51/0A method fo403/CHENP/2004 1 0 PHARMACEUA61K-31/1Disclosed h NOVARTIS AG::CH::CH403/DEL/2003 1 0 A PROCESSA61K-31/0A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN403/MAS/2002 1 0 A PROCESS A61K-31/4The presentA. RAJASEKA. RAJASEKARAN::IN::IN403/MUM/2003 1 0 A PROCESSA61K-31/4A process f CADILA HEALTHCARE LTD::IN::IN404/MUM/2002 1 0 A PROCESSA61K-31/0A process f EMCURE PHARMACEUTICALS LIMITED::IN::IN405/CHENP/2004 1 0 A METHOD A61K-9/20The present H. LUNDBECK A/S::DK::DK405/DELNP/2003 1 0 "PROCESS A61K-9/00The present BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG::DE::DE4068/DELNP/2007 1 0 "SOLID PA A61K-9/51The present AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION::AU::AU411/MAS/2002 1 0 AN IMPROVA61K-31/1ABSTRACT Th M/S. NATCO PHARMA LTD::IN::IN4136/DELNP/2006 1 0 "PHARMACEA61K-9/16The present FOURNIER LABORATORIES IRELAND LIMITED::IE::IE4136/DELNP/2007 1 0 "A PIPERI A61K-31/4The present EURO-CELTIQUE, S.A.::LU::LU4138/DELNP/2007 1 0 "A PIPERI A61K-31/4The present EURO-CELTIQUE, S.A::LU::LU413/MUM/2012 1 0 "A GREENEA61K-31/0Sulfonamide4143/CHENP/2008 1 0 COMPOSITIA61K-31/4The presentROSSIGNOL,ROMARK LABORATORIES, L.C.::US::US4144/KOLNP/2009 1 0 PROCESS FA61K- 9/16A process HOVIONE INTER LTD.::CH::CH414/MUM/2008 1 0 A PROCESSA61K-9/12,The deliver CLARIS LIFESCIENCES LIMITED::IN::IN415/CAL/1995 1 0 A PROCESSA61-K 31/2Lobaplatin ZENTARIS GMBH::DE::DE415/DELNP/2004 1 0 "A METHODA61K-49/0A method foDOUGLAS DZILA BIOTECHNOLOGY, INC.::US::US415/DEL/2002 1 0 AN IMPROVA61K-35/7The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN415/MUMNP/2003 1 0 A METHOD A61-K 31/3A method fo NANJING ZHENZHONG BIOENGINEERING COMPANY LTD.::CN::CN417/CHE/2003 1 0 AN IMPROVA61K-9/00A method fo NEULAND LABORATORIES LTD::IN::IN4180/DELNP/2005 1 0 "METHOD OA61K-51/0"METHOD OF GE HEALTHCARE LIMITED::GB::419/MAS/2002 1 0 PROCESS FA61K-31/4This invent AURBINDO PHARMA LIMITED::IN::IN420/DEL/2000 1 0 "A PROCESA61K-31/0A process f RHONE-POLENC RORER S.A.::FR::FR421/DEL/2000 1 0 "A PROCESA61K-31/0: This inve RHONE-POULENC RORER S.A.::FR::FR4227/DELNP/2012 1 0 "POLYMERIA61K-8/43Biguanide- COLGATE-PALMOLIVE COMPANY::US::US423/KOLNP/2003 1 0 A METHOD A61K-31/1A method o CEPHALON INC::US::US424/KOL/2003 1 0 PROCESS FA61K-39/0The present425/MUM/2004 1 0 AN ANTITUA61-K 31/4A process fSANJEEV KSANJEEV KHANDELWAL::IN::IN42/MUMNP/2009 1 0 IMPROVEMEA61K-9/16A process f UNILEVER PLC::PY::PY
SHALOM SHABAT::IL::ILJUDITH ARONHIME::IL::IL
JAN WILLEM GROENENDAAL::NL::NLEVERARDUS JOHANNUS ANTONIUS MARIA LEENDERTS::NL::NLA.R. RAMESHA::IN::INA.K. ROY::IN::IN
JOSHI, SHREERANG VIDHYADHAR::IN::INCHANDAVARKAR, MOHAN ANAND::IN::INGEETHA K.G::IN::NDR. MUHAMMED MAJEED::IN::I
KANAGARAJ SURESHKUMAR::IN::INHITESH CHANDRAPRAKASH SHARMA::IN::INTETALI SATYANARAYANA VARA PRASAD REDDY::IN::INCHANDAR BHAR::IN::INGROTHER Leon Paul::GB::BRZOZOWSKI Andrzej Jan::GB::GBRAO TIPPANU THIRUPATHI::IN::INJAIN KULDEEP NATWARLAL::IN::INCANDILLON Pascal::FR::FRLAFOSSE Julien::FR::
process for preparing an acylated cellobiose satisfying the general formula in which X epresents_ani acyl group -R-CO- or II. Z represents an acyl group R" -CO- m*i Kand not more than a minority of R + 11' residues represent H and in the remaining R + R' residues. R represents a saturated or unsaturated, linear or branched chain hydrocarbon residue containing from 5 to 31 carbon atoms and R" represents a residue which is different fromJ3_aLd_which is > (0 a saturated or unsaturated, linear or branched chain hydrocarbon residue containing from 1 to 31 carbon atoms optionally substituted or \ii) an aiorr.ai hydrocarbon residue, optionally substituted or (iii) a cycloaiiphatic hydrocarbon, optionally substituted <""" \ -â– '" said process comprising the step ot reacting an acylated dfellobiose having general r lormula 2 V Ol in which X represents an acyl group (R-CO-) or H. being not more than a minority X residues and R represents a saturated or unsatuniicd. linear or branched chain hydrocarbon residue containing from 5 to 31 carbon atoms with an acylating agent 1 icontainiim a residue R' preferentially at the anomenc carbon of the cellobiosc.WEBB, NICHOLAS::GB::WHITE, MICHAEL STEPHEN::GB::LOHRAY VIDYA BHUSHAN::IN::IN
501/CAL/2002 1 0 A PROCESSA61K-038/The present BOSE INSTITUTE::IN::IN501/CHE/2003 1 0 AN IMPROVA61K-41/5The present ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN503/KOLNP/2006 1 0 A PROCESSA61K-9/24A process fM/S NIRMAM/S NIRMAL MULYE::US::US507/CAL/1997 1 0 A PROCESSA61- K 9/32A process fDEBORAH MWYETH::US::US508/CAL/2001 1 0 A METHOD A61K-38/0The present INNAPHARMA, INC.::US::US508/CHE/2004 1 0 A PROCESSA61K-9/14The present M/S. NOVARTIS AG::CH::CH50/CHE/2006 1 0 AN IMPROVA61K-31/5The present ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN5149/DELNP/2010 1 0 "CARRIER A61K-9/16The inventi515/CHE/2007 1 0 AN IMPROVA61K-31/0A novel pro GLAND PHARMA LTD::IN::IN517/DEL/2001 1 0 ''PROCESS A61K-31/0The inventi PFIZER RESEARCH AND DEVELOPMENT COMPANY,::IN::IN518/DEL/2001 1 0 "A PROCESA61K-31/0A process f PFIZER RESEARCH & DEVELOPEMENT COMPANY, N.V. S.A.::IE::IE518/MUM/2003 1 0 A PROCESSA61K-7/02A process f USV LIMITED::IN::IN5190/DELNP/2009 1 0 "PROCESS A61K-9/42An object o EISAI R&D MANAGEMENT CO., LTD.::JP::JP519/DEL/2001 1 0 "A PROCESA61K-31/0The inventi PFIZER RESEARCH AND DEVELOPMENT COMPANY,N.V. S.A::IE::519/MUMNP/2010 1 0 ADHERENT A61K- 35/5A method of PLURISTEM LTD.::IL::IL519/MUM/2003 1 0 A METHOD A61-K 031 A method fo USV LIMITED::IN::IN520/DEL/2001 1 0 ''A PROCE A61K-31/0A process fPFIZER LIMPFIZER RESEARCH AND DEVELOPMENT COMPANY,::IE::IE521/CHE/2004 1 0 PROCESS FA61K-31/4The present M/S. MATRIX LABORATORIES LTD::IN::IN522/CHE/2004 1 0 PROCESS FA61K-31/4The present MATRIX LABORATORIES LTD::IN::IN523/CHE/2004 1 0 PROCESS FA61-K 31/4The present MATRIX LABORATORIES LTD::IN::IN526/CHE/2008 1 0 AN IMPROVA61K-31/4The present MSN LABORATORIES LIMITED::IN::IN52/CAL/1999 1 0 PREPARATIA61K-31/5A method foJOHN D. HIGMCNEIL PPC, INC.::US::US52/MUM/2004 1 0 PROCESS FA61K-31/64Stable oral USV LIMITED::IN::IN531/MUM/2004 1 0 PROCESSESA61-K 38/8A process f GLENMARK PHARMACEUTICALS LIMITED::IN::IN532/DEL/2005 1 0 "FULVIC A A61K-35/8A process f JAMIA HAMDARD (HAMDARD UNIVERSITY)::IN::IN533/DEL/2003 1 0 AN IMPROVA61K-31/0This inven COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN533/MUM/2008 1 0 PROCESS FA61K-31/5The present SHELAR ASHOK RANGANATH::IN::IN534/MUM/2008 1 0 DIAMINO PA61K-31/50The present SHELAR ASHOK RANGANATH::IN::IN5350/CHENP/2007 1 0 PROCESS FA61K-31/4Disclosed NAKANISHI,SHIONOGI & CO LTD::JP::JP535/DEL/2002 1 0 "GEL COMPA61K-7/00Two-phase gBUTUC, STEPENRECO::US::US535/DEL/2003 1 0 "A PROCESA61K-31/3The inventi COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN5392/CHENP/2008 1 0 A PROCESSA61K-9/221 ABSTRACT NIPPON SODA CO; LTD.::JP::JP539/DELNP/2004 1 0 "BENZOTHIA61K-31/5A benzothia ASTRAZENECA AB::SE::SE540/MAS/1999 1 0 A METHOD A61K-9/10This invent540/MAS/2002 1 0 METHOD FOA61K-31/0A method of M/S. ORCHID CHEMICALS & PHARMACEUTICALS LTD,::IN::IN541/DEL/2003 1 0 A PROCESSA61K-31/1The present COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN542/DEL/2003 1 0 "AN IMPROA61K-35/7This invent COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN545/CHENP/2004 1 0 A COMPOSIA61K-38/0This invent STEM CELL THERAPEUTICS INC::CA::CA546/MUM/2003 1 0 A PROCESSA61K-9/00A process f5476/DELNP/2005 1 0 "A PROCESA61K-31/5A process f TIBOTEC PHARMACEUTICALS LTD::IE::IE548/DEL/2002 1 0 "PROCESS A61K-031/The present BAYER HEALTHCARE AG.::DE::DE5515/DELNP/2005 1 0 "STABILIZ A61K-38/2A method fo NOVO NORDISK A/S::DK::DK551/DEL/2004 1 0 "A PROCESA61-K 35/6The present COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN552/MAS/1998 1 0 PREPARATA61K-09/1The presentDR. TSONGSCHERING CORPORATION::US::US5552/DELNP/2005 1 0 "BLOOD POA61K-49/0The use of BRACCO IMAGING S.P.A.::IT::IT559/MUMNP/2006 1 0 MEDICAMENA61K-35/6Honey is tr CAMELYN LTD::GE::GE560/CHE/2005 1 0 IMPROVED A61K-31/5The present ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN562/DELNP/2005 1 0 "A METHODA61K-35/7A method of GW PHARMA LIMITED::GB::
DR. DIPANKAR BHATTACHARYA::IN::INPROF. DR. PARIMAL CHANDRA SEN::IN::INANANDAM VEMPALI::IN::INSRINIVASU GHANTA::IN::IN
NOBEL JOHN FOWLER::US::USHLAVKA JOSEPH JOHN::US::USDR. BARBARA HAEBERLIN::CH::CHDR. ARMIN MEINZER::DE::DERAMAR PADMANABHAN::IN::INANNADURAI MARIMUTHU SENTHILKUMAR::IN::INWOLFGANG KEMPE::DE::DEBURKHARD SCHLUTERMANN::DE::DE
ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD::CH::CHADD TECHNOLOGIES LTD.::CH::CHS. SATHIYANARAYAN::IN::IN
DANIEL JOSEPH CHRISTIAAN THONE::BE::BEDR. WERNER HEILMANN::DE::DEDR. HERBERT DIEHL::DE::DEJUUL-MORTENSEN CLAUS::DK::DKENGELUND DORTE KOT::DK::DKAVINASH PRAHLAD SATTUR::IN::INAPPURAO GOPALRAO APPU RAO::IN::IN
BROCCHETTA, MARINO::IT::ITANELLI, PIER LUCIO::IT::ITKADAGISHVILI. Eliso (GE/GE]::GE::GEABASHIDZE, Guguli [GE/GE]::GE::GEPRABHAT KUMAR SAHOO::IN::INANANDAM VEMPELLI::IN::INCOLIN A. HILL::GB::GBBRIAN ANTHONY WHITTLE::GB::GB
566/CHE/2004 1 0 PROCESS FA61-K31/4The present M/S. MATRIX LABORATORIES LTD::IN::IN567/MUM/2003 1 0 NOVEL META61K-31/1A process f CADILA HEALTHCARE LIMITED::IN::IN568/KOL/2003 1 0 A PROCESS A61-K 31/4Processes a WYETH.::US::US5719/DELNP/2005 1 0 "METHOD FA61K-9/00The method GALDERMA S.A.::CH::CH571/CHE/2003 1 0 AN IMPROVA61K-9/22The present #N/A571/DEL/2007 1 0 "A COMPOUA61K-31/0Compounds aMEL BLUM:WHITE FLOWER ASSOCIATES LLP::US::US5739/DELNP/2006 1 0 PROCESS FA61K-31/0The present TIANJIN TASLY PHARMACEUTICAL CO. LTD::CN::CN573/MUM/2004 1 0 PROCESS FA61K-9/20The present M/S. ARCH PHARMALABS LIMITED::IN::IN575/CAL/2000 1 0 A PROCESSA61K- 31/5The invent AMERICAN HOME PRODUCTS CORPORATION::US::US577/MUM/2005 1 0 A PROCESSA61K-31/6ABSTRACT A KISHORE MNANO CUTTING EDGE TECHNOLOGY PVT. LTD.::IN::IN580/MUM/2002 1 0 A NOVEL MA61K-9/20A novel met L M. COLLEGE OF PHARMACY::IN::IN581/CHENP/2007 1 0 METHOD FOA61K-31/6Novel synth VASCULAR BIOGENICS LTD::IL::IL5827/DELNP/2005 1 0 "A METHODA61K-9/16A method fo JOHN CLAUDE SAVOIR::MX::MX5885/DELNP/2006 1 0 "PROCESS A61K-33/4A process f KUREHA CORPORATION::JP::JP58/CHENP/2003 1 0 A CONTROLA61K-9/20This invent58/DEL/2007 1 0 AN INDUSTA61K-31/4The present IND-SWIFT LABORATORIES LIMITED::IN::IN590/CHE/2004 1 0 PROCESS FA61K-31/1The inventi DIVI'S LABORATORIES LIMITED::IN::IN5936/DELNP/2005 1 0 "A METHODA61K-31/5A method foYOSO TOMOOTSUKA PHARMACEUTICAL CO., LTD.::JP::JP593/MAS/2000 1 0 PROCESS FA61K-31/0The present M/S.F HOFFMANN-LA ROCHE AG::SZ::SZ594/MUMNP/2011 1 0 ââ‚C07D- 473/The present ELI LILLY AND COMPANY::US::US596/CHE/2005 1 0 IMPROVED A61K-31/4The present ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN5980/CHENP/2008 1 0 METHOD FOA61K-2/28ABSTRACT Th SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION::KR::KR598/MAS/2002 1 0 PROCESSESA61K-31/0The presentKONAKANCHNATCO PHARMA LIMITED::IN::IN598/MUM/2002 1 0 NEW PROCEA61-K 31/01. Process LES LABORATOIRES SERVIER::FR::FR5/CHE/2006 1 0 A PROCESSA61K-31/0A process t ACTAVIS PHARMA MANUFACTURING PRIVATE LIMITED::IN::IN6028/DELNP/2007 1 0 "A METHODA61K-9/16The present NYCOMED PHARMA AS::NO::NO603/CHE/2003 1 0 AN IMPROVA61K-01/4The present606/CHE/2003 1 0 PROCESS FA61-K 31/5The present AUROBINDO PHARMA LIMITED::IN::IN606/MUMNP/2004 1 0 METHOD FOA61K-31/11. Method f HEMOTEQ AG::DE::DE6094/DELNP/2005 1 0 "RESOLUTIA61K-31/2The presentEDWARD D.CYMABAY THERAPEUTICS, INC::US::US60/DEL/2000 1 0 "PROCESS A61K-31/0This invent SMITHKLINE BEECHAM CORPORATION::US::US6130/DELNP/2005 1 0 "A PROCESA61K-31/6The present WARNER CHILCOTT COMPANY, LLC::US::US613/DEL/2003 1 0 "A PROCESA61K-38/0A process f UNIVERSITY OF DELHI,::IN::IN615/MAS/2000 1 0 A PROCESSA61K-31/0The present F HOFFMANN-LA ROCHE AG::CH::CH61/DEL/2000 1 0 "PROCESS A61K-31/0A process f SMITHKLINE BEECHAM CORPORATION::US::US61/MUMNP/2009 1 0 A PROCESSA61K-9/16A process f UNILEVER PLC::PY::PY621/DELNP/2009 1 0 "COMPOSITA61K-9/14A process f THE PROCTER & GAMBLE COMPANY::US::US623/CHE/2005 1 0 PROCESS FA61-K31/3A process f MYLAN LABORATORIES LTD::IN::IN626/CHENP/2006 1 0 METHOD FOA61K-47/4The present NEKTAR THERAPEUTICS AL, CORPORATION::US::US627/MUM/2003 1 0 A PROCESSA61K-31/4A process f6286/DELNP/2006 1 0 "A PROCESA61K-31/4A process f GRUNENTHAL GMBH::DE::DE632/KOLNP/2007 1 0 "METHOD FA61K- 47/2There is pr VITAL HEALTH SCIENCES PTY LTD.::AU::AU635/CHENP/2008 1 0 ADHESIVE A61K-9/00The present SENJU PHARMACEUTICAL Co.,Ltd.,::JP::JP638/CHE/2003 1 0 A PROCESSA61K-31/6The present M/S. MATRIX LABORATORIES LTD::IN::IN639/MUM/2005 1 0 METHOD FOA61-K 31/5A process f IPCA LABORATORIES LTD.::IN::IN63/CHE/2007 1 0 A PROCESSA61K-31/4ABSTRACT A SANOFI-AVENTIS DEUTSCHLAND GMBH::DE::DE63/KOLNP/2006 1 0 CONJUGATEA61K-47/4The compou ORTHO MCNEIL PHARMACEUTICAL, INC::US::US63/KOL/2005 1 0 "A PROCESA61K-8/92A process fPAUL,AMITWACKER METROARK CHEMICALS PVT,LTD.::IN::IN
CAROL M KINOSHITA::US::USPRASHSANT MISHRA::US::USJOHN NICHOLAS STANIFORTH::GB::GBMICHAEL JOHN TOBYN::GB::GBLISA MARIE SCHULTZE::US::USDAPHNE EVETTE KELLY::US::USMAHALE GANESH DEVIDAS::IN::INKUMAR ASHOK::IN::INGRANGER Stewart Paton::GB::GBBARRETT Karen Elizabeth::GB::GB
740/DEL/2005 1 0 A PROCESSC07J-9/00,The present COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN744/DEL/1998 1 0 "A PROCESA61K-31/0A process f COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN745/CHENP/2003 1 0 A PROCESSA61K-38/5The present M/S. HETERO DRUGS LIMITED::IN::IN746/CHENP/2003 1 0 PROCESS FA61K-31/5The present M/S. HETERO DRUGS LIMITED::IN::IN7480/DELNP/2006 1 0 "PROCESS A61K-31/4A process f UOP LLC::US::US748/CHENP/2003 1 0 PROCESS FA61K-31/0The present HETERO DRUGS LIMITED::IN::IN754/CHENP/2007 1 0 "PROCESS A61K-31/4A Novel pro BIOCON LIMITED::IN::IN755/MUM/2003 1 0 A PROCESSA61K-31/4A process o ARISTO PHARMACEUTICAL LTD.::IN::IN756/DEL/2010 1 0 "AN IMPROA61K-31/1The present DIRECTOR GENERAL, DEFENCE RESEARCH & DEVELOPMENT ORGANISATION::IN::IN7586/DELNP/2009 1 0 "A METHODA61K-47/4A method is WYETH LLC::US::US758/CHE/2003 1 0 PROCESS FA61K-31/5The present ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN759/DEL/2002 1 0 A PROCESSA61K-31/0A process f RANBAXY LABORATORIES LIMITED::IN::IN75/CHE/2005 1 0 PROCESS FA61K-31/4A process f GLOCHEM INDUSTRIES LIMITED::IN::IN760/MAS/2002 1 0 AN IMPROVA61K-31/5A process f M/S. ORCHID CHEMICALS & PHARMACEUTICALS LTD.,::IN::IN763/MAS/2000 1 0 A PROCESSA61K-37/6The present F. HOFFMANN-LA ROCHE AG::CH::CH765/DEL/2003 1 0 "A PROCESA61K-9/00This invent LIFECARE INNOVATIONS PVT LTD::IN::IN767/DEL/2000 1 0 "A PROCESA61K-31/0Process for COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN769/MUM/2002 1 0 A PROCESSA61-K 009/A process f VAVIA PRADEEP RATILAL::IN::IN7703/DELNP/2006 1 0 "METHODSA61K-39/3Methods for THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES::US::US770/MUM/2006 1 0 AN IMPROVA61K-9/00,Disclosed FDC LIMITED::IN::IN771/DEL/2002 1 0 A method foA61-K 31/1The present Ranbaxy Laboratories Limited::IN::IN772/DEL/2000 1 0 "AN IMPROA61K-31/0This invent COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN772/KOL/2005 1 0 A PROCESSA61K-39/0Resurgence BOSE INSTITUTE::IN::IN773/MUM/2001 1 0 PROCESS FA61-K 31/4A process fMRS. D'SOUMRS. D'SOUZA PHILO BEN.::IN::IN777/CHENP/2003 1 0 PROCESS FA61K-31/4The present M/S. HETERO DRUGS LIMITED::IN::IN778/CHENP/2003 1 0 PROCESS FA61K-9/20The present HETERO DRUGS LIMITED::IN::IN781/MAS/2001 1 0 2 - AMINOA61K-31/0The inventi Dr. SHAMANNA MOHAN::IN::IN7820/DELNP/2006 1 0 "A PROCESA61K-9/00A process fPOUL BERTNYCOMED DANMARK APS::DK::DK782/CHE/2005 1 0 A NOVEL PA61K-31/5A novel pr MANNE STYANARAYANA REDDY::IN::IN783/DELNP/2009 1 0 "A METHODA61K-9/16A process f NOVARTIS AG::CH::CH785/MAS/2002 1 0 AN IMPROVA61K-31/5The present M/S. ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN785/MUMNP/2003 1 0 METHODS FA61K-31/0A method fo PFIZER PRODUCTS INC.::US::US78/KOL/2003 1 0 AN IMPROVA61K-31/1The inventiNADKARNI TORRENT PHARMACEUTICALS LTD.::IN::IN7906/DELNP/2008 1 0 BIORESORBA61K-9/14A novel met LIDDS AB::SE::SE792/MUMNP/2003 1 0 PROCESS FA61-K 7/50. A processTSAUR, LI HINDUSTAN UNILEVER LIMITED::IN::IN794/CHE/2004 1 0 AN IMPROVA61K-31/5This invent AUROBINDO PHARMA LIMITED,::IN::IN794/DEL/2001 1 0 "A PROCESA61K-39/0The inventi#N/A #N/A79/MUM/2003 1 0 A PROCESSA61K-33/4A process f CADILA HEALTHCARE LTD.::IN::IN800/MAS/2002 1 0 AN IMPROVA61K-031/The present806/CHE/2003 1 0 A PROCESSA61K-31/1An industri AUROBINDO PHARMA LIMITED::IN::IN807/MUM/2005 1 0 A process fA61K-31/4Disclosed h IPCA LABORATORIES LTD.::IN::IN818/MUM/2003 1 0 STABLE PHA61K-31/4The present CADILA PHARMACEUTICALS LTD.::IN::IN81/KOLNP/2009 1 0 PROCESS FA61K- 9/16A process f ASAHI KASEI CHEMICALS CORPORATION::JP::JP820/DEL/2002 1 0 "A PROCESA61K-6/00A process f HAMDARD UNIVERSITY::IN::IN820/MUM/2003 1 0 A NOVEL HA61K-9/48A method of L.M. COLLEGE OF PHARMACY::IN::IN823/MUM/2003 1 0 THE PROCEA61-K 35/0Process for ALKEM LABORATORIES LTD.::IN::IN825/DELNP/2003 1 0 " NOVEL C A61K-31/4The present TEVA PHARMACEUTICAL INDUSTRIES LTD.::IL::IL825/MAS/2002 1 0 A PROCESSA61K-31/7THE PROCELEISTER R SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES & TECHNOLOGY::IN::IN
MEENAKSHISUNDERAM SIVAKUMAR.::IN::INKumar,Ashok::IN::INGautam,Prashant::IN::INJITENDRA MOHANSINGH BAWEJA::IN::INALMA SRINIVAS REDDY::IN::INYOSHIHITO YAGINUMA::JP::JPRIKA MATSUMOTO::JP::JPSAMINA RAHMAN::IN::INJAVED ALI::IN::INMUKESH CHHAGANLAL GOHEL::IN::INRAJESH KANTILAL PARIKH::IN::INS. B. APTE::IN::INB. P. SINGH::IN::INETI KOVALESVSKI-ISHAI::IL::ILGUY SAMBURSKI,::IL::IL
831/KOLNP/2007 1 0 PROCESS FC07D- 307/A process f TAKEDA PHARMACEUTICAL COMPANY LIMITED::JP::JP839/DEL/2002 1 0 "A NOVEL A61K-9/20A method fo RANBAXY LABORATORIES LIMITED::IN::IN840/DEL/2004 1 0 "AN IMPROA61K-31/0This invent DIRECTOR GENERAL,DEFENCE RESEARCH AND DEVELOPMENT ORGANISATION::IN::IN840/MUMNP/2003 1 0 METHOD TOA61K-9/16A method of ASTRAZENECA AB::SE::SE843/MAS/1999 1 0 DERMATOLOA61K-33/3ABSTRACT DeS.S.VANAGAAPEX LABORATORIES LIMITED::IN::IN845/DEL/2000 1 0 "A PROCESA61K-9/24The present REGISTRAR, UNIVERSITY OF DELHI,::IN::IN847/KOLNP/2006 1 0 "TUBULIN C07D-213/7Compounds o YM BIOSCIENCES AUSTRALIA PTY LTD::AU::AU857/DEL/2001 1 0 A PROCESSA61K-35/7The process COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN858/CHE/2003 1 0 AN IMPROVA61K-31/4Present inv NATCO PHARMA LIMITED::IN::IN858/MAS/1999 1 0 A PROCESSA61K-47/4A water-solAPOLLON PF. HOFFMANN-LA ROCHE AG::CH::CH859/CHE/2003 1 0 "AN IMOROA61K-039/The present AUROBINDO PHARMA LIMITED,::IN::IN85/DEL/2003 1 0 A PROCESSA61K-8/19This inventR.P. SINGH:R.P. SINGH::IN::IN85/MUM/2002 1 0 A PROCESSA61-K 9/20A process f CADILA HEALTHCARE LIMITED::IN::IN862/MUM/2002 1 0 A PROCESSA61-K 31/7A process f ALEMBIC LIMITED::IN::IN863/CHE/2003 1 0 "AN IMPROA61K-31/4The objecti DR. REDDY'S LABORATORIES LIMITED::IN::IN863/DEL/2003 1 0 "A PROCESA61K-31/4The presen NATIONAL INSTITUTE OF IMMUNOLOGY.::IN::IN863/MAS/2002 1 0 A PROCESSA61K-7/16In this inv875/CHENP/2004 1 0 A PROCESSA61K-9/16The inventi ROHM GMBH & CO. KG::DE::DE879/DEL/2002 1 0 "A PROCESA61K-31/0This invent PFIZER PRODUCTS, INC.::US::US881/DEL/2001 1 0 A process fA61-K 31/0The inventi Ranbaxy Laboratories Limited::IN::IN881/DEL/2002 1 0 "A PROCESA61-K 31/0This invent PFIZER PRODUCTS, INC.::US::US882/DEL/2002 1 0 "A PROCESA61-K 31/0This invent PFIZER PRODUCTS, INC.::US::US8937/DELNP/2008 1 0 STABILIZE A61K-9/20A stabilize AUXILIUM INTERNATIONAL HOLDINGS,INC.::US::US8/DEL/2002 1 0 "METHOD OA61K-9/08The present NATIONAL INSTITUTE OF HEALTH & FAMILY WELFARE,::IN::IN9002/DELNP/2008 1 0 "A METHODA61K-9/16It is inten #N/A #N/A907/CHE/2007 1 0 A PROCESSA61K-31/0The present MYLAN LABORATORIES LIMITED::IN::IN9159/DELNP/2008 1 0 ââ‚A61K-31/4A syntheti NEKTAR THERAPEUTICS.,::US::US947/DEL/2007 1 0 "PROCESS A61K-35/0The inventi HERAEUS PRECIOUS METALS GMBH & Co. KG::DE::DE951/DELNP/2004 1 0 "A PROCESA61K-31/3A process f INDENA S.P.A.::IT::IT9781/DELNP/2007 1 0 "SNAR PROA61K-31/4Provided ar990/CHENP/2010 1 0 NEW COMPOA61K-51/0The inventi LABORATOIRES CYCLOPHARMA::FR::FR9943/DELNP/2008 1 0 "PROCESS FA61K-31/4The present EUTHYMICS BIOSCIENCE, INC.::US::USIN/PCT/2000/00089/DEL 1 0 "A METHODA61K-31/7The present BAXTER INTERNATIONAL INC.::US::USIN/PCT/2000/00253/DEL 1 0 "Dual compoA61K-7/16A method fo Colgate-Palmolive Company::US::USIN/PCT/2000/00266/MU 1 0 PROCESS FA61K- 9/00Process for BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG.::DE::DEIN/PCT/2000/00286/MU 1 0 "A PROCESA61- K 31/5A process f BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG.::DE::DEIN/PCT/2000/00302/DEL 1 0 "A PROCESA61K-9/12The inventi EUROCELTIQUE S.A.::LU::LUIN/PCT/2000/00304/DEL 1 0 "A PROCESA61K-9/12The inventi EURO-CELTIQUE S.A.::LU::LUIN/PCT/2000/00312/MU 1 0 A METHOD A61K-47/4Method for BIOALLIANCE PHARMA(S.A.)::FR::FRIN/PCT/2000/00328/DEL 1 0 "A CONTINA61K-9/70A continuouMARK RUPESTOWIC RESOURCES LIMITED::GB::IN/PCT/2000/00528/KOL 1 0 "A PROCESA61-K 9/54The inventi ETHYPHARM::FR::FRIN/PCT/2000/00706/MU 1 0 PROCESS FA61K-7/16Silica part CROSFIELD LIMITED::GB::GBIN/PCT/2000/238/KOL 1 0 A PROCESSA61K-9/00A PROCESS ORTHO-MCNEIL PHARMACEUTICAL INC.,::US::USIN/PCT/2000/474/CHE 1 0 A PROCESSA61K-31/4The present ROCHE DIAGNOSTICS GMBH::DE::DEIN/PCT/2000/496/KOL 1 0 PROCESS FA61K-31/2A process f FUMAPHARM AG::CH::CHIN/PCT/2001/00048/DEL 1 0 A Method foA61K-9/00This inventSeo Hong YSeo Hong Yoo::US::USIN/PCT/2001/00069/MU 1 0 AMORPHOUA61K-31/4"AMORPHOUS SMITHKLINE BEECHAM CORPORATION::US::USIN/PCT/2001/00071/DEL 1 0 "A Process A61-K 35/5The presentMiyares CACentro De Histoterapia Placentaria::CU::CU
SANDIP B. TIWARI::IN::INRAVEENDRA PAI M.::IN::INKESHAV DEO::IN::INV.K.KANSAL::IN::INKOMATI SATYANARAYANA::IN::INVIKAS NAGPAL::IN::INNALINI WALI::IN::INNARVULA KRISHNAMMANAIDU SARASWATHI::IN::INNATESH KARE SUBBARAJA GUPTA::IN::INKASETTY SEETHARAMAIAH SATHYANARAYANA SETTY::IN::IN
NATESH KARE SUBBARAJA GUPTA::IN::INKASETTY SEETHARAMAIAH SATHYANARAYANA SETTY::IN::INMEIER, Christian::DE::DE
GRYCZKE, Andreas::DE::DEJUDITH LEE TREADWAY::US::USMICHAEL PAUL ZAWISTOSKI::US::Gour Mukherji::IN::INAshok Rampal::IN::INMichael Paul Zawistoski::US::MICHAEL PAUL ZAWISTOSKI::US::JUDITH LEE TREADWAY::US::USMICHEL PAUL ZAWISTOSKI::US::KOLENG, JOHN, J.::US::USZHANG, FENG::US::USSANKAR PRASAD CHAKI::IN::INMANMOHAN MISRO::IN::IN
DR. OMDUTT TYAGI::IN::INDR. KARUSALA NAGESWARA RAO::IN::INLIN CHENG::US::UMICHAEL D BENTLEY::US::SKLAUS WUSSOW::DE::DEKNUD REUTER::DE::DE::IT::ITNA::IT::ITDEMATTEI JOHN::US::USBARNETT BRADLEY R.::US::GB
ARRAY BIOPHARMA INC.::US::USASTRAZENECA AB,::SE::SELE JEUNE, JEAN JACQUES::FR::FR
HINDRE, FRANCOIS::FR::FRXU FENG::US::USMURRY JERRY A::US::USGIANGIACOMO TORRIO::IT::ITBEINTO CASU::IT::ITFisher Steven W.::US::USGambogi Robert J.::US::USDIETRICH TURCK::DE::DEVEIT SCHMELMER::DE::DEPETER SIEGER::DE::DEDIETRICH TURCK::DE::DE::CN::::AF::REIMER, KAREN::DE::DEKRAMER AXEL::DE::DECOUVREUR, PATRICK::FR::FRPUISIEUX FRANCIS::FR::FR
IN/PCT/2001/00091/DEL 1 0 "A PROCESA61K-9/16 SOCIETE LABORATORIES DES PRODUITS ETHIQUES-ETHYPHARM::FR::FRIN/PCT/2001/00093/DEL 1 0 "AN ARTIC A61K-31/3The instantMORAN STABioMedicines Inc.::US::USIN/PCT/2001/00117/DEL 1 0 "WATER SOA61K-38/1The inventi THE UNIVERSITY OF KANSAS::US::USIN/PCT/2001/00142/MU 1 0 A METHOD A61K-49/0A method foIN/PCT/2001/00146/MU 1 0 A METHOD A61K-7/16A method fo WARNER-LAMBERT COMPANY LLC::US::USIN/PCT/2001/00191/MU 1 0 ALGINATE A61K-9/16A method ofROLF BJER NORSK HYDRO ASA::NO::NOIN/PCT/2001/00196/MU 1 0 A PROCESSA61-K 31/1A process f EDKO TRADING AND REPRESENTATION COM::TR::TRIN/PCT/2001/00235/MU 1 0 A PROCESSA61K-9/28A process o EASTMAN CHEMICAL COMPANY::US::USIN/PCT/2001/00244/DEL 1 0 "A PROCESA61K-7/16The raw syn COLGATE-PALMOLIVE COMPANY::US::USIN/PCT/2001/00263/MU 1 0 "PROCESS A61-K 9/16A Process f BAYER AKTIENGESELLSCHAFT::DE::DEIN/PCT/2001/00317/MU 1 0 ORAL CAREA61K-7/16The inventi HINDUSTAN UNILEVER LIMITED::IN::ININ/PCT/2001/00345/MU 1 0 A METHOD C11D- 3/22A water-sol HINDUSTAN UNILEVER LIMITED::IN::ININ/PCT/2001/00418/MU 1 0 A METHOD A61-K 47/31. A methodANDREAS BANDREAS BERNKOP-SCHNURCH::AT::ATIN/PCT/2001/00424/DEL 1 0 "A PROCESA61K-9/14Rapidly dis SKYE PHARMA CANADA INC.::CA::CAIN/PCT/2001/00441/DEL 1 0 A METHOD A61K-7/16A method fo COLGATE-PALMOLIVE COMPANY::US::USIN/PCT/2001/00593/DEL 1 0 "METHOD FA61K-51/0Processes f ANTI-CANCER THERAPEUTIC INVENTIONS AS::NO::NOIN/PCT/2001/00595/MU 1 0 A METHOD A61K-31/7A novel, no#N/AIN/PCT/2001/00598/MU 1 0 SUSTAINEDA61K-9/14Disclosed a PENWEST PHARMACEUTICAL CO.::US::USIN/PCT/2001/00636/DEL 1 0 "A PROCESA61K-7/16A two compo COLGATE-PALMOLIVE COMPANY::US::USIN/PCT/2001/00649/DEL 1 0 "A METHODA61K-9/70In a method DERMATECH LIMITED::GB::GBIN/PCT/2001/00690/DEL 1 0 "PROCESS A61K-9/70A process f#N/AIN/PCT/2001/00728/MU 1 0 A COSMETIA61K- 7/48A cosmetic HINDUSTAN LEVER LIMITED::IN::ININ/PCT/2001/00729/DEL 1 0 "AN IMPROA61K-9/19A Factor VIIN/PCT/2001/00733/DEL 1 0 "A PROCESA61K-9/26Oral solid FARMACEUTICI FORMENTI S.P.A.::IT::ITIN/PCT/2001/00764/MU 1 0 A PROCESSA61K-9/50,One aspect USV LIMITED::IN::ININ/PCT/2001/00767/DEL 1 0 "A PROCESA61K-31/5The inventiREGINA GESOLVAY PHARMACEUTICALS GMBH,::DE::DEIN/PCT/2001/01026/DEL 1 0 "FAST-DIS A61K-9/20A process f R.P. SCHERER CORPORATION,::US::USIN/PCT/2001/01060/DEL 1 0 "A PROCESA61K-31/4The inventi LABORATOIRES DES PRODUCTS ETHIQUES ETHYPHARM::FR::FRIN/PCT/2001/01062/MU 1 0 IMPROVED A61K-9/16A method of R. P. SCHERER TECHNOLOGIES, INC.::US::USIN/PCT/2001/01133/DEL 1 0 "A METHODA61K-9/12The inventi IDEA AG::DE::DEIN/PCT/2001/01154/DEL 1 0 A PROCESSA61K-39/3A method ofWAKSAL HAIMCLONE SYSTEMS INCORPORATED,::US::USIN/PCT/2001/01155/DEL 1 0 "A PROCESA61K-7/16An antibact COLGATE-PALMOLIVE COMPANY::US::USIN/PCT/2001/01160/DEL 1 0 "A PROCESA61K-9/16Controlled- COSMO S.P.A::IT::ITIN/PCT/2001/01163/DEL 1 0 "A PROCESA61K-9/16Controlled- COSMO S.P.A.::IT::ITIN/PCT/2001/01181/DEL 1 0 "PROCESS A61K-9/16A process f ETHYPHARM,::FR::FRIN/PCT/2001/01213/MU 1 0 A METHOD A61K-47/1Water-solub NATIONAL RESEARCH COUNCIL OF CANADA::CA::CAIN/PCT/2001/01224/KOL 1 0 A METHOD A61K- 9/50Methods of TALTON JANANOSPHERE INC..,::US::USIN/PCT/2001/01253/MU 1 0 A METHOD A61K-31/5WE CLAIM 1. TEVA PHARMACEUTICAL INDUSTRIES LTD.::IL::ILIN/PCT/2001/01327/MU 1 0 PROCESS FA61K-49/0The present GE HEALTHCARE AS::NO::NOIN/PCT/2001/01343/MU 1 0 A PROCESSA61K-31/4A method of BRIDGE PHARMA INC.::US::USIN/PCT/2001/01366/MU 1 0 A PROCESSA61-K 45/0A process f BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG.::DE::DEIN/PCT/2001/01418/MU 1 0 A METHOD A61K-9/12A method fo BTG INTERNATIONAL LIMITED::GB::GBIN/PCT/2001/1003/CHE 1 0 A METHOD A61K-9/48The present M/S. ROHM GMBH & CO.KG::DE::DEIN/PCT/2001/1475/CHE 1 0 A SUNSCREA61K-7/42The inventi SYMRISE GmbH & CO. KG::DE::DEIN/PCT/2001/402/KOL 1 0 A METHOD A61K-31/5A method of NEW ACE RESEARCH COMPANY::US::USIN/PCT/2001/579/CHE 1 0 A METHOD A61K-31/6This inventIN/PCT/2001/825/CHE 1 0 A METHOD A61K-31/4ABSTRACT I AVENTIS PHARMACEUTICALS, INC::US::USIN/PCT/2001/888/CHE 1 0 METHOD FOA61K-31/3This invent H. LUNDBECK A/S::DK::DK
Process for manufacturing coated particles of y-aminobutyric acid analogue, whose lactam content by weight relative to the weight of ï§aminobutyric, acid analogue is less than 0.5%, charactarired in that a coating solution comprising at least one polymer in an organic solvent is sprayed on to the said particles of y-aminobutyric acid analogue.�CHAUVEAU CHARLES::FR::FRDEMICHELIS ALAIN-GILLES::FR::FR
INGRID GUNDA GEORG::US::MUHAMMED S. SAFADI::IL::YOSHIO INAGAKI::JP::JPTORU HARADA::JP::JP
SCHERING AKTIENGESELLSCHAFT::DE::DEFUJI PHOTO FILM CO; LTD::JP::JPNEEMA KULKARNI::US::US
ALBERT F. SORG::US::US
EMBIL, KORAL::TR::TRFIGUEROA RAY::TR::TRSTEPHEN HONG-WEI WU::US::USMICHAEL WAYNE ADAMS::US::USTAVSS EDWARD A.::US::USJOZIAK MARILOU T.::US::USCLAUS WEISEMANN::US::ERNST CHANTRAINE::US::MOLLOY KEIRAN#N/AWRIGH PHILIP#N/AJONES CHRISTOPHER CLARKSON::GB::GBKHOSHDEL EZAT::GB::GB
ROBERT DONGA::CA::CAMICHAEL G VACHON::CA::CAMANDADI PRAKASARAO::US::USWONG MIKE::US::USLARSEN, ROY H.::NO::NOHENRIKSEN, GJERMUND::NO::NOTEVA PHARMACEUTICAL INDUSTRIES LTD::IL::IL
TEVA PHARMACEUTICAL INDUSTRIES LTD.::IL::ILLIRONG LIU::US::USSTEVE LABUDZINSKI::US::USJOZIAK MARILOU T::US::USMASTERS JAMES G::US::USTOCILI, BILJANA::GB::GBSOLOMON, DAVID LOUIS, CHARLES::GB::GBLTS LOHMANN THERAPIE-SYSTEM AG::DE::DE
LTS LOHMANN THERAPIE-SYSTEME AG::DE::DEROGERS JULIA SARAH::GB::WATKINSON ALLAN::GB::SERGUEI TCHESSALOV,::US::USJOHN CARPENTER::US::US
BAXTER INTERNATIONAL INC.::US::USUNIVERSITY OF CONNECTICUT::US::USFRIMONTI, ENRICO::IT::IT
RICHARD GREEN::GB::PATRICK KEARNEY::GB::PASCAL SUPLIE::FR::FRPASCAL OURY::FR::FRRONALD S. VLADYKA,JR.,::US::USPAMELA R. STERGIOS::US::USRICHARDSEN, HOLGER::DE::DEWEILAND-WAIBEL, ANDREA::DE::DE
SZELES LORI H.::US::USGAFFAR ABDUL::US::USAJANI MAURO::PA::PAFOSSATI LORENZO::PA::PAAJANI, MAURO::PA::PAFOSSATI, LORENZO::PA::PACHAUVEAU CHARLES::FR::FRBRUNA ETIENNE::FR::FRMARIANNA SIKORSKA-WALKER::CA::CAP. ROY WALKER::CA::CA
ANITA LIBERMAN::IL::ILNINA FINKELSTEIN::IL::ILHAUKAR JOHANNESSON::SE::SEJAN HEARIK ARDENKJAER LARSEN::SE::SEGUNNAR A. K.ABERG::US::USJAN L CHEN::US::USRICHARD REICHL::DE::DEALEXANDER WALLAND::DE::ANTHONY DAVID HARMAN::GB::TIMOTHY DAVID BOORMAN::GB::FUCHS, Wolfgang::DE::DESCHIKOWSKY, Hartmut::DE::DETRIVEDI, JAGDISH::US::USWENTWORTH, GARY::US::USDELUCA PATRICK::US::USGEBREKIDAN SISAY::US::USBOLAND, Ricardo::AR::ARPAPAPOULOS, Sokrates, E::NL::NL
GADOR S.A::AR::ARLEIDEN UNIVERSITY MEDICAL CENTER::NL::NLHANLEY STEPHEN J::US::US
COMISKEY STEPHEN J::US::USPETERSEN Hans::DK::DKELLEGAARD Peter::DK::
IN/PCT/2002/00031/DEL 1 0 "A METHODA61K-31/4The present TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION::US::USIN/PCT/2002/00042/MU 1 0 A PROCESSA61K-9/48A process f AAIPHARMA INC.::US::USIN/PCT/2002/00047/MU 1 0 PROCESS FA61K-47/0The inventi BAYER HEALTHCARE AG::DE::DEIN/PCT/2002/00080/MU 1 0 A METHOD A61K-47/0An edible pERIC BEGLEDIMENSIONAL FOODS CORPORATION::US::USIN/PCT/2002/00099/DEL 1 0 "LOW-DOSEA61K-9/50The inventi LABORATOIRES DES PRODUITS ETHIQUES ETHYPHARM::FR::FRIN/PCT/2002/00166/MU 1 0 A PROCESSC07C-317/4A compound ASTRAZENECA AB::SE::SEIN/PCT/2002/00187/DEL 1 0 "PROCESS A61K-31/0The present LTS LOHMANN THERAPIE-SYSTEME AG.::DE::DEIN/PCT/2002/00227/MU 1 0 A PROCESSA61K-31/5A process f NEUROCRINE BIOSCIENCES, INC.::US::USIN/PCT/2002/00238/DEL 1 0 "METHOD OA61K-31/3A method ofPARKS, L. PARKS, L. DEAN[US/US]::US::USIN/PCT/2002/00437/DEL 1 0 "A PROCESA61K-49/0A process fDOUGLAS DZILA INC.::US::USIN/PCT/2002/00451/KOL 1 0 CONJUGATEA61K-47/4The inventi CELL THERAPEUTICS INC.::US::USIN/PCT/2002/00469/DEL 1 0 ''PROCESS A61K-31/1The inventi ELF ANTAR FRANCE::FR::FRIN/PCT/2002/00487/DEL 1 0 "A PROCESA61K-9/00The inventiKRUMME, MLTS LOHMANN THERAPIE-SYSTEM AG::DE::DEIN/PCT/2002/00488/DEL 1 0 "A METHODA61K-9/50A method fo TAGRA BIOTECHNOLOGIES LTD.::IL::ILIN/PCT/2002/00497/DEL 1 0 "A PROCESA61K-31/5The present OSI PHARMACEUTICALS, INC.::US::USIN/PCT/2002/00538/KOL 1 0 A METHOD A61K-31/7There is pr GLAXO GROUP LIMITED::GB::GBIN/PCT/2002/00840/DEL 1 0 CONTROLLEA61K-9/22Controlled AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION::AU::AUIN/PCT/2002/00935/MU 1 0 ANTI- MIC A61K-7/321. A method HINDUSTAN LEVER LIMITED::IN::ININ/PCT/2002/00949/DEL 1 0 "EMULSIONA61K-35/7The relatesSCHEFFLER,BIRKEN GMBH.::DE::DEIN/PCT/2002/00998/MU 1 0 A METHOD A61K-9/20Method of mIN/PCT/2002/01079/DEL 1 0 SUBSTITUTA61K-31/1Title: A pr TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION::US::USIN/PCT/2002/01090/DEL 1 0 "A PROCESA61K-31/4The Present TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION::US::USIN/PCT/2002/01098/MU 1 0 ORALLY ADA61-K 31/4A process f KOPRAN RESEARCH LABORATORIES LIMITED::IN::ININ/PCT/2002/01147/MU 1 0 A METHOD A61K-31/7A process f TEVA PHARMACEUTICAL INDUSTRIES LTD.::IL::ILIN/PCT/2002/01198/DEL 1 0 "A COMPOUA61K-31/1The present YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM::IL::ILIN/PCT/2002/01229/MU 1 0 A METHOD A61K-39/3A method fo GE HEALTHCARE BIO-SCIENCES AB::SE::SEIN/PCT/2002/1483/KOL 1 0 A TOPICALA61K-7/16A method of THE PROCTER & GAMBLE COMPANY::US::USIN/PCT/2002/1487/CHE 1 0 A PROCESSA61K-31/5The present SEPRACOR INC::US::USIN/PCT/2002/150/CHE 1 0 #N/A #N/A #N/A #N/A #N/AIN/PCT/2002/1615/CHE 1 0 A METHOD A61K-9/11The present VECTURA LIMITED::GB::GBIN/PCT/2002/1640/CHE 1 0 A PATCH CA61K-47/4A non-invasFISCHER, WiEPICEPT, INC::US::USIN/PCT/2002/1723/CHE 1 0 A PROCESSA61K-47/1The inventiPETEREIT, M/S. ROHM GMBH & CO. KG::DE::IN/PCT/2002/1760/CHE 1 0 A HEMOSTAA61K-9/00The present BIOLIFE, L.L.C::US::USIN/PCT/2002/1991/CHE 1 0 A METHOD A61K-35/7The present M/S. RECKITT BENCKISER HEALTHCARE (UK) LIMITED::GB::GBIN/PCT/2002/2121/CHE 1 0 METHOD FOA61K-9/20The present F. HOFFMANN-LA ROCHE AG::CH::CHIN/PCT/2002/2129/CHE 1 0 A METHOD A61K-9/14A method fo M/S. VECTURA LIMITED::GB::GBIN/PCT/2002/29/CHE 1 0 A PROCESSA61K-31/3The present H LUNDBECK A/S::DK::DKIN/PCT/2002/459/KOL 1 0 HETEROBIFA61-K 47/4This invent SHEARWATER CORPORATION::US::USIN/PCT/2002/858/CHE 1 0 A METHOD A61K-31/2The prepara NOVARTIS AG::CH::CHIN/PCT/2003/00014/DEL 1 0 "METHOD FA61K-9/08A method fo PHARMATOP SCR::FR::FR
ERAGAMREDDY, PREMKUMAR, REDDY::US::USMOOLE VENKATA, RAMANA REDDY::US::USGLENN A MEYER::US::USFREDERICK D SANCILIO::US::USHANS-FRIEDRICH MAHLER::DE::DEMICHAEL EISELE::DE::DE
PIERRE TCHORELOFF::FR::FRPATRICK SANIAL::FR::FRTHORSTEN NOWAK::GB::GBJEREMY NICHOLAS BURROWS::GB::GBHOFFMANN, HANS-RAINER::DE::DEASMUSSEN, BODO::DE::DEWILLIAM J THIELE::US::USPATRICK B. O'DONNELL::US::US
SHAPIRO, YURY::IL::ILKVITNITSKY, EMMA::IL::ILJEFFREY WILLIAM RAGGON::US::USSANDRA LETA SILBERMAN::US::USGOWER DAVID::GB::GBMOUNTER ANDREW DAVID::GB::GBBARBE, CHRISTOPHE, JEAN, ALEXANDRE::AU::ABARTLETT, JOHN::AU::UMAKIN STEPHEN ANTHONY::GB::MCMILLAN IAN ROBERT::GB::
Healthpoint, Ltd.,::US::USCouncil of Scientific and Industrial Research::IN::INCouncil of Scientific and Industrial Research::IN::INCouncil of Scientific and Industrial Research::IN::INBAXTER INTERNATIONAL INC.::US::USHealthpoint, Ltd.::US::USGLAXO GROUP LIMITED::GB::GBCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INBIOPROGRESS TECHNOLOGY INTERNATIONAL INC::US::USPOLIFARMA S.P.A.::IT::IT
ATOFINA::FR::FRTHE BRIGHAM AND WOMEN'S HOSPITAL INC.::US::USBOEHRINGER INGELHEIM PHARMA GMBH & CO. KG.::DE::DESYMRISE GMBH & CO. KG.::DE::DELANXESS DEUTSCHLAND GMBH,::DE::DESHELAR ASHOK RANGANATH::IN::INAUROBINDO PHARMA LIMITED::IN::INJOHNSON & JOHNSON VISION CARE, INC.,::US::USFDC LIMITED::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INRANBAXY LABORATORIES LIMITED::IN::INNATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH::IN::INADISSEO FRANCE SAS::FR::FRCADILA HEALTHCARE LTD::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INLUPIN LTD.::IN::INGLAND PHARMA LTD::IN::INBAYER HEALTHCARE AG,::DE::DEPANACEA BIOTECH LIMITED::IN::IN
NOVARTIS AG::CH::CHENZON PHARMACEUTICALS, INC.::US::USDSM N.V..,::NL::NLM/S. HETERO DRUGS LIMITED::IN::INMYLAN LABORATORIES LTD::IN::INRANBAXY LABORATORIES LIMITED::IN::INDSM N.V.::NL::NLAnidral S.R.L.::IT::ITTHE CHIEF CONTROLLER RESEARCH & DEVELOPMENT::IN::INFERRING BV::NL::NLCouncil of Scientific and Industrial Research::IN::INORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::IN
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::INNAGARSENKER MANGAL SHAILESH::IN::INRane Manish Subhashchandra::IN::IN
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INFABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (FAES)::ES::ESFABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (FAES)::ES::ESCOLGATE-PALMOLIVE COMPANY::US::USFAES FARMA, S.A.::ES::ESNATCO PHARMA LTD::IN::INCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::IN
JUBILANT ORGANOSYS LIMITED::IN::INNACTILUS AB,::SE::SEM/S. THE BOOTS COMPANY PLC::GB::GB1)PATRAVALE VANDANA BHARAT 2)KHAN IMRAN AHMAD::IN::IN
SUN PHARMACEUTICAL INDUSTRIES LTD.::IN::INRANBAXY LABORATORIES LIMITED::IN::INUNICHEM LABORATORIES LIMITED::IN::INHINDUSTAN LEVER LIMITED::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INDEVARAJAN PADMA VENKITACHALAM::IN::INM/S. CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND::US::USORCHID CHEMICALS AND PHARAMACEUTICALS LTD::IN::INGE HEALTHCARE AS.::NO::NOSREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES & TECHNOLOGY::IN::INM/S. INDOCO REMEDIES LIMITED::IN::INSHAH AMIT NAVNIT::IN::INEMCURE PHARMACEUTICALS LIMITED::IN::INRANBAXY LABORATORIES LIMITED::IN::INLABORATOIRE MEDIDOM S. A.::CH::CHNITEC PHARMA AG.::CH::CHCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::INSKYMAX LABORATORIES PVT LTD.::IN::INSKYMAX LABORATORIES PVT LTD.::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INLUPIN LIMITED::IN::INRANBAXY LABORATORIES LIMITED::IN::INM/S. CIPLA LIMITED::IN::INNATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER),::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INAARTI HEALTHCARE LIMITED::IN::INANACOR PHARMACEUTICALS, INC.::US::USSONIC BIOCHEM EXTRACTIONS LTD.::IN::INSONIC BIOCHEM EXTRACTIONS LTD::IN::INSONIC BIOCHEM EXTRACTIONS LTD::IN::INCRITICAL PHARMACEUTICALS LIMITED::GB::GBCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INWANBURY LIMITED::IN::INELDER PHARMACEUTICALS LTD::IN::IN
M/S. NATCO PHARMA LTD::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INS.ZHAVERI PHARMAKEM PVT.LTD::IN::INJ.S.S. MAHAVIDYAPEETHA::IN::INM/S. ALEMBIC LIMITED::IN::INM/S. TABLETS (INDIA)LIMITED::IN::INMALLADI DRUGS & PHARMACEUTICALS LTD::IN::INNATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)::IN::INSUN PHARMACEUTICAL INDUSTRIES LTD.::IN::INNOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.::BM::BMM/S. IPCA LABORATORIES LIMITED::IN::INSUVEN LIFE SCIENCES LTD::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INM/S. IPCA LABORATORIES LIMITED::IN::INCLARIS LIFESCIENCES LTD.::IN::IN
CADILA HEALTHCARE LIMITED::IN::INPFIZER PRODUCTS INC.,::US::USCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::INSAPTE VINAY RAMAKANT::IN::INJOHNSON & JOHNSON VISION CARE, INC.::US::USM/S. IPCA LABORATORIES LIMITED::IN::INSKYMAX LABORATORIES PVT LTD.::IN::INBAXTER INTERNATIONAL INC.::US::USORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::INAUROBINDO PHARMA LIMITED::IN::INCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::INTEVA PHARMACEUTICAL INDUSTRIES LTD.::IL::ILRANBAXY LABORATORIES LIMITED::IN::INASTELLAS PHARMA INC::JP::JPBASF AKTIENGESELLSCHAFT::DE::DEMYLAN LABORATORIES LTD.::IN::INLAURUS LABS PVT LTD::IN::INCOUNCIL OF SCEINTIFIC AND INDUSTRIAL RESEARCH::IN::INALZA CORPORATION::US::USNOVAGALI PHARMA SA::FR::FRALEMBIC LIMITED::IN::INVIANEX S.A.::GR::GRMILLENNIUM PHARMACEUTICALS, INC.::US::USPANACEA BIOTEC LIMITED::IN::INM/S. MALLADI DRUGS & PHARMACEUTICALS LTD::IN::INM/S. HETERO DRUGS LIMITED::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH,::IN::INJUBILANT ORGANOSYS LIMITED::IN::INLUPIN LIMITED::IN::INAUROBINDO PHARMA LIMITED::IN::INABBOTT LABORATORIES GMBH::DE::DE
BASAVARAJ K. NANJWADE::IN::INF. V. MANVI::IN::IN
ITC LIMITED::IN::INASTRA AKTIEBOLAG,::SE::SEINDIAN INSTITUTE OF TECHNOLOGY::IN::INROHM GMBH & CO. KG::DE::DESCINOPHARM SINGAPORE PTE, LTD.::SG::SG
CIPLA LIMITED::IN::INROHM GMBH & CO. KG::DE::DEDIRECTOR GENERAL, DEFENCE RESEARCH & DEVELOPMENT ORGANISATION.::IN::INAJANTA PHARMA LIMITED::IN::INWOCKHARDT LIMITED::IN::INM/S. CIPLA LIMITED::IN::IN
AUROBINDO PHARMA LIMITED::IN::INTHE UNIVERSITY OF BRITISH COLUMBIA::CA::CACIPLA LIMITED::IN::INALEMBIC LIMITED::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INASTRAZENECA UK LIMITED::GB::GBPFIZER IRELAND PHARMACEUTICALS::IE::MSN LABORATORIES LIMITED::IN::INLEK PHARMACEUTICAL AND CHEMICAL COMPANY D.D.::SI::SIDR. GERHARD MANN CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH::DE::DESCHERING AKTIENGESELLSCHAFT::DE::DE
SOL-GEL TECHNOLOGIES LTD::IL::ILEMCURE PHARMACEUTICALS LTD::IN::INTIOGA PHARMACEUTICALS, INC.::US::USINSTITUT PASTEUR AND INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE::FR::FR
FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y PHARMACEUTICOS, S.A., (FAES)::ES::ESTROMMSDORFF GMBH & CO. KG ARZNEIMITTEL::DE::DECENTAUR CHEMICALS PVT. LTD.::IN::INDUTTA AJOY::IN::INORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::ININDOCO REMEDIES LIMITED::IN::INNATCO PHARMA LIMITED::IN::INOBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIJU "RADA-PHARMA"::RU::RUALOK SAXENA::IN::INMONOSOLRX LLC::US::US
SCITECH CENTRE::IN::INTAKEDA PHARMACEUTICAL COMPANY LIMITED::JP::JPCSIR::ZA::ZASAXENA ALOK::IN::INAMIT ROY CHOWDHURY::IN::INGALDERMA S.A.::CH::CHIPCA LABORATORIES LIMITED::IN::INNATCO PHARAMA LIMITED::IN::INNORTON HEALTHCARE LIMITED::GB::GBCADILA HEALTHCARE LIMITED::IN::INSUMSUNG FINE CHEMICALS CO. LTD.,::KR::KRROHM GmbH & CO. KG::DE::DETEVA PHARMACEUTICAL INDUSTRIES, LTD.::IL::ILPFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./ S.A.::IE::WYETH::US::USCOLGATE-PALMOLIVE COMPANY::US::USCRODA INTERNATIONAL PLC,::GB::GBCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INNATIONAL INSTITUTE OF IMMUNOLOGY::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH,::IN::INNOWICKY, WASSYL::AT::ATGENZYME CORPORATION::US::USMAITY PRASANTA::IN::INCAN-FITE BIOPHARMA LTD::IL::ILMACLEODS PHARMACEUTICALS LIMITED::IN::INM/S. IPCA LABORATORIES LIMITED::IN::IN
INNOPHOS, INC.::US::USCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INUSV LIMITED::IN::INBRACCO INTERNATIONAL B.V::NL::NLMITRA,PUCHALAPALLI::IN::INPFIZER PRODUCTS INC.::US::USTAS SINAN::TR::TR
MSN LABORATORIES LIMITED::IN::INSUEDZUCKER AKTIENGESELLSCHAFT MANNHEIM/PCHSENFURT::DE::DEKRKA, D.D., NOVO MESTO::SI::SI
GE HEALTHCARE AS::NO::NGE HEALTHCARE LIMITED::GB::O
UNIVERSITY OF STRATHCLYDE::GB::GBUNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW::GB::GB
HOSPIRA, INC.::US::USMAGNACHEM INTERNATIONAL LABORTORIES,INC.,::US::USCLARIS LIFESCIENCES LIMITED::IN::INEMCURE PHARMACEUTICALS LTD.::IN::IN
RANBAXY LABORATORIES LIMITED::IN::INMANNKIND CORPORATION::US::USIND-SWIFT LABORATORIES LIMITED::IN::INMANNKIND CORPORATION::US::USCADILA HEALTHCARE LIMITED::IN::INARES TRADING S.A.,::CA::CAIPCA LABORATORIES LIMITED::IN::INZHEJIANG CHARIOTEER PHARMACEUTICAL CO., LTD.::CN::CNALEXZA PHARMACEUTICALS, INC.::US::USDSM IP ASSETS B.V.::NL::NLTHE RICEX COMPANY::US::USAUROBINDO PHARMA LIMITED::IN::INRANBAXY LABORATORIES LIMITED::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INFAULK PHARMACEUTICALS, INC::US::USBRISTOL-MYERS SQUIBB COMPANY::US::USRECKITT BENCKISER HEALTHCARE (UK) LIMITED::GB::GBCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INCIPLA LIMITED::IN::INNEOPHARM, INC.::US::USKAO CORPORATION::JP::JPNIPPON KAYAKU KABUSHIKI KAISHA::JP::JPCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INCENTAUR CHEMICALS PVT. LTD.::IN::INDIRECTOR GENERAL,MINISTRY OF DEFENCE, DEFENCE RESEARSH & DEVELOPMENT ORGANIZATION::IN::INM/S. IND-SWIFT LIMITED::IN::INSMITHKLINE BEECHAM PLC::GB::INDIAN INSTITUTE OF TECHNOLOGY, BOMBAY::IN::INICEUTICA PTY LTD::AU::AUM/S. RECKITT BENCKISER (UK) LIMITED::GB::
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INACADIA PHARMACEUTICALS INC.::US::USCouncil of Scientific and Industrial Research,::IN::INSAMJIN PHARMACEUTICAL CO. LTD.,::KR::KRPFIZER PRODUCTS INC::US::USCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::ININDIAN COUNCIL OF AGRICULTURAL RESEARCH::IN::INCOUNCIL OF SCEINTIFIC AND INDUSTRIAL RESEARCH::IN::INJINA PHARMACEUTICALS INC.::US::US
Dr. Kishori Ganpat Apte::IN::INDr. Vaishali Vasant Potnis::IN::IN
EURO-CELTIQUE S.A.,::LU::LUINDENA S.P.A.::IT::ITTHE DIRECTOR GENERAL-DEFENCE RESEARCH & DEVELOPMENT ORGANISATION.::IN::INGLAXO GROUP LIMITED::GB::GBIPCA LABORATORIES LTD.::IN::INH. LUNDBECK A/S::DK::DKINDOCO REMEDIES LIMITED::IN::INDR. GURDIAL SINGH ARORA::IN::INPEJO ISERLOHN HEILMITTEL UND DIAT GMBH & CO KG::DE::DEM/S. TABLETS (INDIA) LIMITED::IN::INM/S. DSM N.V::NL::NL
SUVEN LIFE SCIENCES LIMITED::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH,::IN::INIPCA LABORATORIES LIMITED::IN::INSMITHKLINE BEECHAM P.L.C.::GB::ICEUTICA PTY LTD.::AU::AUVIRIDIS BIOPHARMA PVT. LTD.::IN::IN
AVENTIS PHARMA S.A .::FR::FRANORMED,INC.::CA::CACOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INM/S. EDWARD MENDELL CO, INC::US::USUSV PRIVATE LIMITED::IN::INPOWDERJECT RESEARCH LIMITED::GB::GBTHE CHINESE UNIVERSITY OF HONG KONG::CN::CNSMITH KLINE BEECHAM P.L.C.::GB::
LES LABORATOIRES SERVIER::FR::FRCJ CHEILJEDANG CORPORATION::KR::KRINDOCO REMEDIES LIMITED::IN::INASTRAZENECA AB::SE::SEMYLAN LABORATORIES LTD::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN
TORRENT PHARMACEUTICALS LTD.::IN::INACADIA PHARMACEUTICALS INC.::US::USDR. REDDY'S LABORATORIES LIMITED::IN::INCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INBOEHRINGER INGELHEIM PHARMA GMBH & CO. KG.::DE::DEIPSEN PHARMA S.A.S.,::FR::FRCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INBOEHRINGER INGELHEIM PHARMA GMBH & CO. KG.::DE::DENOVO NORDISK A/S::DK::DKCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INDIVI'S LABORATORIES LTD.,::IN::INWOCKHARDT LIMITED::IN::IN
COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::INRIEMSER ARZNEIMITTEL AG.::DE::DEBAYER PHARMA AKTIENGESELLSCHAFT,::DE::DERANBAXY LABORATORIES LIMITED::IN::INMCNEIL-PPC, INC.::US::USLIFECARE INNOVATIONS PVT. LTD.::IN::INLIFECARE INNOVATIONS PVT. LTD.::IN::INM/S. THE ARYA VAIDYA PHARMACY (COIMBATORE)LIMITED::IN::IN
NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)::IN::INCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::ININTERHEALTH NUTRACEUTICALS INCORPORATED::US::US
DABUR PHARMA LIMITED::IN::INNATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH::IN::INCHIRON CORPORATION::US::US
IPCA LABORATORIES LTD.::IN::IN
CHR. HANSEN, INC.::US::USCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INORCHID CHEMICALS & PHARAMACEUTICALS LTD::IN::IN
BAXTER INTERNATIONAL INC.::US::USTHAR TECHNOLOGIES, INC.,::US::US
NEULAND LABORATORIES LIMITED::IN::INPHARMACIA CORPORATION::US::USCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH,::IN::INOTSUKA PHARMACEUTICAL CO., LTD.,::JP::JPM/S BAKUL FINECHEM RESEARCH CENTRE::IN::INRHONE-POULENC RORER S.A.::FR::FRPANACEA BIOTEC LIMITED::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INIPCA LABORATORIES LIMITED::IN::IN
CREABILIS S. A.::LU::LUCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::IN
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::INORGANOBALANCE GMBH::DE::DEM/S. NATCO PHARMA LTD::IN::INWYETH::US::USR L FINE CHEM::IN::INFMC BIOPOLYMER AS::NO::NOASTRAZENECA AB::SE::SEWYETH::US::USAZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A::IT::ITCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INREDX PHARMA LIMITED::GB::GBCOUNCIL OF SCEINTIFIC AND INDUSTRIAL RESEARCH::IN::INMARS INCORPORATED::US::USTHE DIRECTOR GENERAL, DEFENCE RESEARCH & DEVELOPMENT ORGANISATION (DRDO)::IN::INSBL PRIVATE LIMITED::IN::INUNIVERSITY OF ZURICH::CH::CHKONTEST CHEMICALS LTD.::IN::INWARJNER-LAMBERT COMPANY::US::US
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH,::IN::INM/S. SOLVAY PHARMACEUTICALS B.V::NL::NLCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INPANTEC AG::CH::CHCADILA HEALTHCARE LIMITED::IN::IN
DR. REDDY'S LABORATORIES LIMITED::IN::INDR. REDDY'S LABORATORIES INC.::US::US
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INHINDUSTAN ANTIBIOTICS LIMITED,::IN::IN
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE::FR::FRL'UNIVERSITY MONTPELLIER II::FR::FR
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK::US::USHEALTH RESEARCH, INC.,::US::US
M/S. BIOCON LIMITED::IN::INMATRIX LABORATORIES LTD::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INH.LUNDBECK A/S::DK::DKUNIVERSITY OF DELHI::IN::IN
COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::INM/S. IPCA LABORATORIES LTD.::IN::INNATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)::IN::INNATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)::IN::INALEMBIC LIMITED::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INBASILEA PHARMACEUTICA AG::CH::CHJUBILANT ORGANOSYS LTD.::IN::INB BRAUN MELSUNGEN AG::DE::DEETHYPHARM::FR::FRINDIAN COUNCIL OF AGRICULTURAL RESEARCH::IN::INNOVARTIS AG::CH::CHZILA, INC.::US::USH. LUNDBECK A/S::DK::DKDAIICHI SANKYO COMPANY, LIMITED::JP::JPMITSUBISHI CHEMICAL CORPORATION::JP::JPERYTECH PHARMA::FR::FRUSV LIMITED::IN::INPFIZER PRODUCTS INC::US::USCHIEF CONTROLLER OF RESEARCH AND DEVELOPMENT, MINISTRY OF DEFENCE, GOVERNMENT OF INDIA::IN::INCHIESI FARMACEUTICI S.P.A.::IT::ITBASF AKTIENGESELLSCHAFT::DE::DE
RANBAXY LABORATORIES LIMITED::IN::INLUPIN LIMITED::IN::INCIBA HOLDING INC.::CH::CHZILA BIOTECHNOLOGY, INC.::US::USNTNU TECHNOLOGY TRANSFER AS::NO::NONORTON HEALTHCARE ,LTD.,::GB::GBRANBAXY LABORATORIES LIMITED,::IN::INM/S. IPCA LABORATORIES LIMITED::IN::INRANBAXY LABORATORIES LIMITED::IN::INJOHNSON & JOHNSON VISION CARE, INC.::US::US
SMITHKLINE BEECHAM P.L.C.,::GB::GB
Council of Scientific and Industrial Research::IN::INSMITHKLINE BEECHAM CORPORATION::US::USLVMH RECHERCHE::FR::FRLTS LOHMANN THERAPIE-SYSTEME AG::DE::DEM/S. APHTON CORPORATION::US::USSUN PHARAMACEUTICAL INDUSTRIES LTD::IN::IN
GLAND PHARMA LTD::IN::INPFIZER RESEARCH AND DEVELOPMENT COMPANY,::IN::INPFIZER RESEARCH & DEVELOPEMENT COMPANY, N.V. S.A.::IE::IEUSV LIMITED::IN::INEISAI R&D MANAGEMENT CO., LTD.::JP::JPPFIZER RESEARCH AND DEVELOPMENT COMPANY,N.V. S.A::IE::PLURISTEM LTD.::IL::ILUSV LIMITED::IN::INPFIZER RESEARCH AND DEVELOPMENT COMPANY,::IE::IEM/S. MATRIX LABORATORIES LTD::IN::INMATRIX LABORATORIES LTD::IN::INMATRIX LABORATORIES LTD::IN::INMSN LABORATORIES LIMITED::IN::INMCNEIL PPC, INC.::US::USUSV LIMITED::IN::INGLENMARK PHARMACEUTICALS LIMITED::IN::INJAMIA HAMDARD (HAMDARD UNIVERSITY)::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INSHELAR ASHOK RANGANATH::IN::INSHELAR ASHOK RANGANATH::IN::INSHIONOGI & CO LTD::JP::JPPENRECO::US::USCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INNIPPON SODA CO; LTD.::JP::JPASTRAZENECA AB::SE::SE
M/S. ORCHID CHEMICALS & PHARMACEUTICALS LTD,::IN::INCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::INCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::INSTEM CELL THERAPEUTICS INC::CA::CA
WHITE FLOWER ASSOCIATES LLP::US::USTIANJIN TASLY PHARMACEUTICAL CO. LTD::CN::CNM/S. ARCH PHARMALABS LIMITED::IN::INAMERICAN HOME PRODUCTS CORPORATION::US::USNANO CUTTING EDGE TECHNOLOGY PVT. LTD.::IN::INL M. COLLEGE OF PHARMACY::IN::INVASCULAR BIOGENICS LTD::IL::ILJOHN CLAUDE SAVOIR::MX::MXKUREHA CORPORATION::JP::JP
IND-SWIFT LABORATORIES LIMITED::IN::INDIVI'S LABORATORIES LIMITED::IN::INOTSUKA PHARMACEUTICAL CO., LTD.::JP::JPM/S.F HOFFMANN-LA ROCHE AG::SZ::SZELI LILLY AND COMPANY::US::USORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::INSEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION::KR::KRNATCO PHARMA LIMITED::IN::INLES LABORATOIRES SERVIER::FR::FRACTAVIS PHARMA MANUFACTURING PRIVATE LIMITED::IN::INNYCOMED PHARMA AS::NO::NO
COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INM/S. HETERO DRUGS LIMITED::IN::INM/S. HETERO DRUGS LIMITED::IN::INUOP LLC::US::USHETERO DRUGS LIMITED::IN::INBIOCON LIMITED::IN::INARISTO PHARMACEUTICAL LTD.::IN::INDIRECTOR GENERAL, DEFENCE RESEARCH & DEVELOPMENT ORGANISATION::IN::INWYETH LLC::US::USORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::INRANBAXY LABORATORIES LIMITED::IN::INGLOCHEM INDUSTRIES LIMITED::IN::INM/S. ORCHID CHEMICALS & PHARMACEUTICALS LTD.,::IN::INF. HOFFMANN-LA ROCHE AG::CH::CHLIFECARE INNOVATIONS PVT LTD::IN::INCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INVAVIA PRADEEP RATILAL::IN::INTHE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES::US::USFDC LIMITED::IN::INRanbaxy Laboratories Limited::IN::INCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH::IN::INBOSE INSTITUTE::IN::INMRS. D'SOUZA PHILO BEN.::IN::INM/S. HETERO DRUGS LIMITED::IN::INHETERO DRUGS LIMITED::IN::INDr. SHAMANNA MOHAN::IN::INNYCOMED DANMARK APS::DK::DKMANNE STYANARAYANA REDDY::IN::INNOVARTIS AG::CH::CHM/S. ORCHID CHEMICALS & PHARMACEUTICALS LTD::IN::INPFIZER PRODUCTS INC.::US::USTORRENT PHARMACEUTICALS LTD.::IN::INLIDDS AB::SE::SEHINDUSTAN UNILEVER LIMITED::IN::INAUROBINDO PHARMA LIMITED,::IN::IN
CADILA HEALTHCARE LTD.::IN::IN
AUROBINDO PHARMA LIMITED::IN::INIPCA LABORATORIES LTD.::IN::INCADILA PHARMACEUTICALS LTD.::IN::INASAHI KASEI CHEMICALS CORPORATION::JP::JPHAMDARD UNIVERSITY::IN::INL.M. COLLEGE OF PHARMACY::IN::INALKEM LABORATORIES LTD.::IN::INTEVA PHARMACEUTICAL INDUSTRIES LTD.::IL::ILSREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES & TECHNOLOGY::IN::IN
TAKEDA PHARMACEUTICAL COMPANY LIMITED::JP::JPRANBAXY LABORATORIES LIMITED::IN::INDIRECTOR GENERAL,DEFENCE RESEARCH AND DEVELOPMENT ORGANISATION::IN::INASTRAZENECA AB::SE::SEAPEX LABORATORIES LIMITED::IN::INREGISTRAR, UNIVERSITY OF DELHI,::IN::INYM BIOSCIENCES AUSTRALIA PTY LTD::AU::AUCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH::IN::INNATCO PHARMA LIMITED::IN::INF. HOFFMANN-LA ROCHE AG::CH::CHAUROBINDO PHARMA LIMITED,::IN::INR.P. SINGH::IN::INCADILA HEALTHCARE LIMITED::IN::INALEMBIC LIMITED::IN::INDR. REDDY'S LABORATORIES LIMITED::IN::INNATIONAL INSTITUTE OF IMMUNOLOGY.::IN::IN
ROHM GMBH & CO. KG::DE::DEPFIZER PRODUCTS, INC.::US::USRanbaxy Laboratories Limited::IN::INPFIZER PRODUCTS, INC.::US::USPFIZER PRODUCTS, INC.::US::USAUXILIUM INTERNATIONAL HOLDINGS,INC.::US::USNATIONAL INSTITUTE OF HEALTH & FAMILY WELFARE,::IN::IN
BAXTER INTERNATIONAL INC.::US::USUNIVERSITY OF CONNECTICUT::US::US
GADOR S.A::AR::ARLEIDEN UNIVERSITY MEDICAL CENTER::NL::NL
TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION::US::USAAIPHARMA INC.::US::USBAYER HEALTHCARE AG::DE::DEDIMENSIONAL FOODS CORPORATION::US::USLABORATOIRES DES PRODUITS ETHIQUES ETHYPHARM::FR::FRASTRAZENECA AB::SE::SELTS LOHMANN THERAPIE-SYSTEME AG.::DE::DENEUROCRINE BIOSCIENCES, INC.::US::USPARKS, L. DEAN[US/US]::US::USZILA INC.::US::USCELL THERAPEUTICS INC.::US::USELF ANTAR FRANCE::FR::FRLTS LOHMANN THERAPIE-SYSTEM AG::DE::DETAGRA BIOTECHNOLOGIES LTD.::IL::ILOSI PHARMACEUTICALS, INC.::US::USGLAXO GROUP LIMITED::GB::GBAUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION::AU::AUHINDUSTAN LEVER LIMITED::IN::INBIRKEN GMBH.::DE::DE
TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION::US::USTEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION::US::USKOPRAN RESEARCH LABORATORIES LIMITED::IN::INTEVA PHARMACEUTICAL INDUSTRIES LTD.::IL::ILYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM::IL::ILGE HEALTHCARE BIO-SCIENCES AB::SE::SETHE PROCTER & GAMBLE COMPANY::US::USSEPRACOR INC::US::US